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Small Nuclear Ribonucleoproteins 
Chapter 1 
INTRODUCTION 
Since the discovery (Tan and Kunkel, IO66; Mattioli and Peichlin, 
1971; Sharp, et al., 1972) of human SLE autoantibodies directed against 
RNA-protein complexes in eucaryotic nuclei, a great deal of interest has 
been generated regarding both the relationships of antibody specificities 
to disease and the biological roles of the recognized antigens. These 
antibodies are some of the many autoantibody species which have been 
described in systemic lupus erythematosus (SLE) as well as other rheimatic 
disease conditions. A common feature of many of these reactivities is the 
apparent nuclear localization of antigen. Study of the antibodies as well 
as these antigens has led to formation of a particularly unique bridge 
between clinical medicine and basic science questions in cellular biology 
and metabolism. 
The spectrum of diseases which present with antibodies directed 
against cellular constituents is vast although certain features of these 
conditions imply common aspects which may, furthermore, be of some 
diagnostic use. Familial clustering and HLA associations (Grimet, et al., 
1971; Nies, et al., 1974; Kissmeyer-Nielsen, et al., 1975; Arnett and 
Shulman 1.976; Goldberg, et al., 1976; Horn, et al., I07o qchur and 
Carpenter 1993) have pointed to genetic factors which may relate to common 
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etiologies or distinguish among certain of these diseases (libofsky, et 
al., 1973). This group of diseases includes SLE, mixed connective tissue 
disease (MCTP), scleroderma, Sjogren's syndrome, rheumatoid arthritis, 
polymyositis, dermatomyositis, and overlap syndromes. 
The observation of antinuclear antibodies was probably first reported 
in the description of the LE cell (Hargraves, et al., 194P). This 
phenomenon, thought to reflect phagocytosis of antibody coated nuclei by 
polymorphonuclear leukocytes, has historically provided useful diagnostic 
information. Three reports in 1957 (Holman and Kunkel, lf>'=^"'; Friou, et 
al,, 1<^57; Holborrow, et al., 1057) utilized fluorescent antinuclear 
antibody binding to demonstrate the presence of antinuclear components in 
serum of patients with a variety of disorders. The report (Barnett 107-7) 
of low antinuclear antibody titers in a significant proportion of normals 
has suggested that the simple presence of such immunoglobulins may not be 
pathological (in low titers). With increasingly sophisticated methods of 
analysis, more detailed study of these autoantibodies has been carried out 
resulting in the elucidation of better defined antigen-antibody systems as 
disease markers and prognostic indicators. 
Numerous autoantibody-antigen systems have been described in 
considerable detail, the majority involving antibodies to nuclear 
components. The indirect immunofluorescence technique has had very wide 
use in analysis of such antibodies. Microscopic analysis has revealed 
several distinguishable patterns of staining which have been shown to 
correspond to different antigenic specificities (Tan ioo9>. The diffuse 
nuclear staining which frequently characterizes anti-DNA antibo-dies differs 
from speckled staining (typical of antibodies to certain saline extractable 
nuclear antigens). Other patterns of staining include "rim," nucleolar. 
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and centromere/kineticore, each corresponding to distinct antigenic 
recognition patterns. TVo potential hazards in interpretation of the 
indirect immunofluorescence test are losses of antigen during washing 
procedures from the fixed cells and possible denaturation effects capable 
of distorting antigen recognition due to the use of certain fixatives (Tan 
1932), 
Cytoplasmic antigen recognition has also been seen in a variety of 
conditions. Antibodies reactive with ribosomes were described in lO'^'? 
(Schur, et al., 1967). The two antigen systems Ro and La likely reside, 
though perhaps not exclusively, in the cytoplasm (Clarke, et al,, 19^0; 
Mattioli and Reichlin, 1974). 
V/hile antinuclear antibodies are associated with a variety of 
rheinatic diseases, certain other conditions may also present with this 
category of antibody reactivity. Nuclear autoantibodies have been 
described in melanoma, nasopharyngeal carcinana, and acute and chronic 
leukemia patients (Morton, et al., 196«; McBride, et al., 1Q7:?. yoshida, et 
al., 1975; Lamelin, et al., 1Q7P; viein, et al., 107/^. steiner, et al., 
1975). Chronic liver disease (Ziegler, et al., 1Q75) may also be 
associated with such autoantibodies including cytoplasmic microsomal 
reactivity (Oavis T931) and the antimitochondrial antibodies (Davis i9Pi) 
seen in primary biliary cirrhosis (Ahrens, et al., 1^50). 
At approximately the same time as the first reports of nuclear-
reactive serun components, came the observations of DNA-reactive antibodies 
(Robbins, et al., 1957; Cepellini, et al., 1957; Seligmann, 1957). use of 
immunodiffusion analysis (Tan, et al., 1966) allowed for the distinction of 
two differing specificities of DNA reactive antibodies. Sera were described 
which reacted with both native (double stranded) and heat denatured DNA, 
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while others reacted with only heat denatured DMA. Tn addition to these 
specificities, a third reactivity sp)ecific only for native nN» has been 
described to occur at low frequency (Arana and Seligmann, 1967; Tan and 
Natali 1970; Koffler, et al., 1971; and Gilliam, et al., 1930). While 
antibodies reactive with native DNA appear generally to recognize 
determinants on the sugar-phosphate backbone (Stollar 1P70; Picazo and Tan 
10*75; samaha and Irwin io7«^; steinman, et al., 19'^'^) single strand DNA 
specific antibodies appear to recognize the nitrogen bases (Tan io32). An 
intriguing distinction between these two anti DNA reactivities is the 
relative ease with which antibodies to single stranded DN^ are induced by 
immunization in animals as compared with a corresponding difficulty for 
dsDNA (Tan 1032), although certain animal models of SLE contain such native 
DNA antibodies. 
Clinical correlations with anti-DNA antibodies have been numerous, 
both in suggesting possible etiology of tissue injury in SLE and as a 
diagnostic marker. The importance of immune complexes in generation of 
glomerulonephritis and vasculitis was demonstrated both for exogenous 
antigen administration in models of serin sickness (Dixon, et al., 1^59, 
1061) and by direct injection of preformed immune complexes (McCluskey, et 
al., 1960), Vasculitic and glomerular lesions were shown by 
immunofluorescence to contain antibody deposits as well as associated C, 
further implicating such immune complexes in a pathogenic role in SLE 
(Vasquez and Dixon, 1957; Mellors, et al., 1Q57; paronetto and Koffler, 
1965; Lachnann, et al., 1962). The sequential appearance of DfA reactive 
antibodies followed by a rise in free serim DNA antigen with loss of serum 
DNA antibody during a SLE flare was highly suggestive that the DNA antigen 
antibody system was functionally important in SLE tissue damage (Tan, et 
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al., 1966). Immunofluorescence and elution techniques demonstrated both 
DNA antigen and DNA reactive antibodies in affected renal glomeruli. While 
the involvement of DNA antigen antibody complexes in glomerular and 
vasculitic lesions appears firmly established, correlations of disease 
activity with DNA antibody titers cannot exclurie consideration of antigen 
load since these two parameters must likely occur within certain 
stoichiometric constraints to form pathogenic immune complexes (Tan "•oqo). 
Antibody to native DNA is most frequently associated with SLE, although 
titers (usually lowl have been observed in other of the rheumatologic and 
connective tissue diseases (Tan 1932; Davis 1931). single stranded DNA 
reactive antibodies have much wider disease distribution including 
rheumatoid arthritis, chronic active hepatitis, and infectious 
mononucleosis (Koffler, et al., 1971). 
Histone reactive antibodies (Kunkel et al., I960; Stollar 1971) have 
been detected in lupus (both idiopathic and drug induced) and in rheumatoid 
arthritis (Tan 1032). Lupus induced by pharmacologic agents (e.g. 
procainamide, hydralazine, and isoniazid) is very frequently associated 
with histone reactive antibodies (Fritzler and Tan, 1073) while such 
reactivity is less frequently observed in idiopathic SLE. Ttie possibility 
that certain {xirified rheumatoid factors may contain anti DNA-histone 
reactivity suggests intriguing relationships between these otherwise 
distinct classes of autoantibodies (Alspaugh, et al., 1973; Agnello, et 
al., 1973; Hannestad and Stollar 1973). 
Other groups of autoantibody-antigen systems include the Ro and La 
antigens which are RNA containing nucleoprotein complexes. These antibody 
reactivities are generally thought to be confined to SLE and Sjogren's 
syndrome (Alspaugh, et al., 1976; Kassan, et al., 1977; Akizuki, et al.. 
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]077; provost 1079). Antibodies to proliferating cell nuclear antigen 
(PCNA) described by Myachi, et al. (107q) are seen in a small proportion of 
SLE patients. Other autoantibodies include centromere/kinetichore (Moroi, 
et al,, 1030; Brenner, et al., 1931), a 70 kd antigen reactive with certain 
scleroderma sera (Douvas, et al., 1979b), and a nuclear antigen recognized 
by antibodies in a significant proportion of rheunatoid arthritis sera 
(Alspaugh, et al,, 107^; Alspaugh and Tan 1976). Several additional 
systems have been described in dermato/polymyositis and overlap syndromes. 
Among these are the PM-1 (Wolfe, et al., 1977), Mi-1 (Nishikai and Reichlin 
1930a), Jo-1 (Nishikai and Reichlin lOPOb), and vu (Mimori, et al., I^PI) 
antigen systems. 
Many of the nuclear antigens recognized by these numerous categories 
of autoantibodies are easily removed from nuclei by isotonic extraction. 
The Sm/RNP antigen antibody system was first described in i066 (Tan and 
Kunkel 19'^'^) as a saline extractable nuclear antigen. While other antigens 
are also saline extractable, the Sm and RNp systems contain several 
distinguishing features which have facilitated identification of these 
reactivities. Analysis of precipitin patterns has distinguished these 
reactivities (Northway and Tan 1.072). Use of a hemagglutination assay 
aided in differentiating between Sm and RNP, and is used as a clinical test 
for these antigens (Tan and Peebles 1976). Sm and RNP reactive antibodies 
generally reveal a speckled pattern of nuclear staining by indirect 
immunofluorescence. 
Initial investigations regarding the molecular composition of the 
Sm/RNP antigens and reactivities revealed RNP sensitivity to RNase 
digestion while Sm recognition displayed no such sensitivity (Northway and 
Tan 19*72). The anti-Sm antibodies are highly specific for SLE while anti-
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RNP antibodies show wider distribution and have helped in defining the 
mixed connective tissue disease syndrome (Sharp, et al., if^7p). This 
disease was described in rheumatologic patients with features of SLE, 
scleroderma, and dermato/polymyositis whose sera contained antibodies 
directed against an RNase sensitive nuclear component. Ttie frequent 
occurance of Raynaud's phenomenon and the absence of renal disease also 
characterized this disorder. At nearly the same time, Mattioli and 
Reichlin (19*^1) reported the occurance of an RNase sensitive extractable 
nuclear antigen called Mo. Reactivity with this antigen was seen in 30 to 
50% of SLE patients, and it was subsequently shown to be identical to RNP 
(Tan, et al,, 1977), So while Sm reactivity shov/s high specificity for SLE 
(although seen in only 30-40% of patients), RNP reactivity can be seen in 
SLE or MCTD, as well as discoid lupus, scleroderma, rheumatoid arthritis, 
and Sjogren's syndrome (Tan 1032). 
Notman, et al., (1975) tested numerous patients for RNP reactivity and 
observed uniformly high titers in MCTD patients and lower frequency of high 
titer in SLE as well as other syndromes. There has been some uncertainty 
over the classification of MCTD as a distinct disease syndrome. 
Distinguishing MCTD from dermato/polymyositis and scleroderma may be of 
particular importance because of the good response to steroid therapy of 
the former, but not the latter disease (Tan 1037). MCTD appears to be 
distinguishable from other related syndromes by the presence of high titers 
exclusively to RNP- other conditions more likely reveal additional antibody 
reactivities (Tan and Peebles 197?;), Thus, Sm antigen reactivity is seen 
in 30-40% of SLE patients and represents a specific disease marker; RNP 
reactivity, while seen in a variety of disorders, may contribute 
significantly to the diagnosis of MCTD (in the absence of other antibody 
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reactivities) and is associated with favorable prognosis in those cases. 
Since the discovery of Sm antigen reactivity in i96^ (Tan and Kunkel, 
196^=^) and RNP in the early 1070's (Mattioli and Reichlin "«Q7i; sharp, et 
al., 1072; Northway and Tan 1077) numerous studies have been carried out, 
aimed at defining the biochemical composition of these nuclear antigens. 
Northway and Tan (1977) used DEAE chromatography, gel filtration, and 
sucrose density centrifugation to show that while some Sm reactivity could 
be isolated separate from RNP, the rest always copurified with RNP-reactive 
antigen. This finding was confirmed by Mattioli and Reichlin (io"77). 
Numerous reports have been made regarding the putative protein constituents 
of snRNPs. While little agreement appeared at first, a consensus is 
beginning to emerge from reports of recent years, Douvas, et al, fio70a) 
used anti RNP affinity columns to describe two proteins of T* and "^o kd. 
Takano et al. (1031) described RNP antigens of 30 kd, 13 kd, and '^^ kd 
while Sm antigen appeared to be several peptides in the 1'^ kd weight range. 
Agelli, et al.. (1930) described a =^5 kd protein thought to be Sm. Waelti 
and Hess (lOPO) identified putative Sm antigens of 110 and 7D ^a. Barque, 
et al. (1931) described 4 Sm and RNP polypeptides in the 10-70 kd weight 
range. White and Hoch (1931) described several Sm and RNP peptides using 
immunoblots. Lerner and Steitz (107Q) reported 7 peptides in the weight 
35 
range of 12-35 kd, immunoprecipitable from ~S-methionine labeled Ehrlich 
ascites mouse cells, itiis pattern of peptides ranging from 32,000 d to 
9,000 d and named A through G, has been recognized by a number of 
independant investigators in recent years (Conner, et al., 1032; Matter, et 
al., 1932; Kinlaw, et al., 1933; Wieben, et al., 1033). 
Lerner and Steitz (1979) demonstrated that immunoprecipitates from 
nuclear extracts using Sm and RNP sera contained U series small nuclear RNA 
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species. While Sm sera precipitated Ui, U2, u^, U5, and U^, RNP sera 
precipitated Ul RNA only. These observations both assigned a biochemical 
niche to these previously described RNA's and provided the suggestion that 
Sm and RNP antibodies may be of great use in further analysis of structural 
and functional properties of the U RNA containing complexes. 
The U series small nuclear RNAs comprise 0.1-1% of total cellular RNA. 
They were named (Hodnett and Busch l9^o) for their uridylic acid-rich 
nucleotide composition. Small nuclear RNAs have been identified in normal 
and malignant cells, vertebrates, invertebrates, dinoflagellates, and 
plants (Reddy and Busch, 1933). Numerous small RNA species have been 
identified in addition to these U RNAs. The 7s species (Bishop, et al., 
1970) is one which has been demonstrated (Walter and Blobel 19^2) to 
participate in a known biological activity. In association with several 
peptides, this RNA forms the signal recognition particle shown to be 
critical in polysome-endoplasmic reticulum interactions during translation 
of membrane and secretory proteins (Walter and Blobel I03ia,b; Walter, et 
al., 1931). Another small RNA with known functional importance is the 
species contained in the e. coli RNase p complex, a particle involved in 
tRNA maturation (Kole and Altman 19*79) . Ttiese two small RNAs (7s and RNase 
P) differ from U series RNA in lacking 5' caps. The U RNAs all contain 
methylated caps at their 5' ends and are RNA polymerase II transcripts, as 
demonstrated by alpha-amanitin sensitive transcription. Trimethylguanosine 
(Saponara and Enger 1969) was identified in Ul, U2, and [P RNAs (Reddy, et 
al., 1972)- present in a =^'-5' triphosphate linkage (Rottman, et al., lo7/i; 
Ro-Choi, et al., 1075; Reddy, et al., 1976). Fbllowing the discovery of 
these caps on U RNAs, similar such caps were discovered in viral and 




Ul RNA was identified as a nuclear species by cell fractionation 
(Weinberg and penman 1963; Hodnett and Busch IO^P). Sequence analysis has 
led to postulated models which predict a secobdary structure involving 
formation of ^ hydrogen bonded stems (see Figure 1) (^-'rol, et al., lOPia). 
Enzymatic digestion followed by immunoprecipitation (Epstein, et al., lopi) 
suggests 2 regions of susceptibility: the 7 most 5' nucleotides, and the 
region near nucleotide 107. These regions (particularly the 5' end which 
undergoes less 2^ folding, see Figure 1) are good candidates for 
participation in the formation of transient base pairs with splice 
junctions. After Ul RNA the next most abundant small nuclear RNA species 
is U2. This species contains 2'-0-methylated nucleotides and an unusual 
number of pseudouridine residues at its 5' end. A U7-like species has been 
found in wheat and differs only slightly from rat U7. u^ RNA is a 
nucleolar sp>ecies, capable of hydrogen bonding to 35S and 2*^^ RNAs 
(Prestayko, et al., 107i) and is not precipitated by Sm or RNP sera. It 
resides as a ribonucleoprotein complex in nucleoli (Prestayko, et al., 
1971). U^ is another nucleoplasmic species containing the 
trimethylguanosine cap (Krol, et al., 1931 a; Reddy, et al., IOPI). it 
bears extensive homology to Ul and is highly conserved (as is the case with 
the other u RNAs)(Krol, et al., 1031). U5 RNA is the most uridine rich u 
RNA (Krol, et al., 1931b). It also contains the trimethylguanosine cap 
(Krol, et al., 1931a). Tn contrast to the other U RNAs, the U6 RNA species 
lacks trimethylguanosine in its cap and contains numerous methylated 
nucleotides in its central sequences. Other U species are methylated on 
nucleotides towards the 5' end of the molecule. Ttie suggestion that U6 may 
associate with newly transcribed RNA (Reddy and Busch, 10P3) may implicate 
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this species in some aspect of RNA processing. 
Ttie synthesis and metabolism of U RNAs is of considerable interest in 
relation to snRNPs. Larger than mature precursors of Ul and U2 have been 
identified in the cytosol following H-uridine pulse labeling (Elcieri 
1974; Fredericksen and Hellung-Larsen 19''5; Zieve and Penman io7^), 
Salditt-Georgieff, et al., (1930) have identified snRNA precursors by 
virtue of their methylated cap structures. u\^ irradiation (to which snRNTA 
transcription is sensitive^ has suggested transcription units for Ui and U7 
as large as 5 kb (Elcieri 1070). Transcription thus appears to be followed 
by very rapid (<10 minutesl transport of precursor species to the cytoplasm 
where further methylation (processing) may occur.. Within i5 minutes, 
mature forms of these U RNAs appear in the nucleus- these nuclear forms 
being quite stable as would perhaps be expected if the RNAs were associated 
with proteins, TVo additional sets of experiments have been carried out 
which bear on cellular location of these RNAs, Microinjection of the RNAs 
in the cytoplasm is followed by transport into the nucleus, where they are 
associated with snRNP proteins (DeRobertis, et al., 1937), Nuclear 
transplantation in ameba (Goldstein, et al., 19'77) has suggested that U 
RNAs shuttle between the nucleus and cytoplasm. A considerable proportion 
of snRNPs have been suggested to associate with the nuclear matrix 
(Vogelstein and Uxint 1932). Deng, et al. (1931) have shown an intriguing 
change in location of sm antigen related to the cell cycle, Sm reactivity 
can be seen in the nucleus during Gi and S. However, Sm antigen appears to 
be located outside the nucleus during G2 and away from the chromatin during 
mitosis. Several unique features of the genes encoding U RNAs have been 
described. Ttie genes appear to be dispersed throughout the genome although 
with similar immediate surroundings (Roop, et al, 1051; Manser and 
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Gesteland 1931; Denison, et al., IOPI; Manser and Gesteland 19^7). itjese 
genes lack intervening sequences and polyadenylation signals (AATAAA near 
the 3' end of the RNA) (Reddy and Busch lop-?; Roop, et al., lOPi; Manser 
and Gesteland 1032). As many as 10 fold more pseudogenes exist for Ui-7 
RNAs than true genes (Denison, et al., lOPi). 
Based on various structural features of the Ui R^^a, the suggestions 
have been made (Lerner, et al., 1930; Rogers and Wall 1<^30) that this 
species may participate in RNArRNA splicing. U RNAs have been seen to 
associate with hnRNPs (Sekeris and Niessing lO""^) and to be capable of 
hydrogen bonding to hnRNA (Northemann, et al., 1077; Northemann, et al., 
1079). Crosslinking studies have also identified ui and U7 RNAs in 
association with hnR^!A (Calvet and Pederson 2031; Calvet, et al., 1OP2). A 
consensus sequence found near the 5' end of Ul RNA bears homology with 
known splice junctions. This 5' end sequence is identical in all known m 
species. Ul RNA containing snRNPs appear to be capable of binding to 5' 
splice junctions in vitro (Mount, et al., 1033). Several experiments have 
demonstrated selective blocking of splicing events when anti-Ul snRNp 
antibodies were added to isolated nuclear (Yang, et al., lOPi) or in vitro 
(Padgett, et al., 19«*3) transcription/splicing systems. Ttje splicing 
activity of another in vitro transcription/splicing system has been shown 
to reside in a fraction containing snRNPs (Hernandez and Keller 1033). 
Perhaps argueing against this role for Ul RNA in splicing is the 
observation of Weissman, et al. (19^2). Ttie splicing efficiency of globin 
precursor RNAs which contained changes in the Ul homologous consensus 
sequence was high, despite lost complementarity to Ul. Other roles for 
which U RNAs have been postulated include transport (Reddy and Busch, 1937; 
Hellung-Larsen and Fredericksen i077), control of transcription (Britten 
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and Davidson '}^'=>9; Prestayko, et al., 107i; Hellung-Larsen and Fredericksen 
1977; Light and Molin i937), and chromatin structure (Pederson and Bhorjee 
19*79). 
Considerably more is known at the structural and biochemical level 
about the U RNA species than the proteins with which they associate in 
snRNPs. Since these proteins undoubtedly underly a significant role in the 
structure and perhaps function of snRNPS, further study of these species 
may be useful in improving the understanding of snRNP particles. Ttie four 
following chapters describe experiments carried out with that purpose, 
making use of the naturally ocurring antibodies reactive with snRNps, those 
of the Sm and RNP specificities seen in SLE and allied autoimmune diseases. 

Figure 1 






































































































Protein Constituents of snRNPs 
ABSTRACT 
The protein constituents of small nuclear ribonucleoproteins (snR^Tps> 
35 
have been analyzed by S-methionme internal labeling followed by 
immunoprecipitation with SLE sera. The eight peptides termed A-G were 
identified and further studied by in vitro translation analysis. Each 
protein was synthesized by the wheat germ cell free extract in the presence 
of appropriate RNA. Furthermore, protease digestion studies and RNA 
fractionation coupled to in vitro translation have revealed that these 






Endogenous Labeled SnRNP Proteins 
Considerable controversy has historicaly surrounded questions of the 
identity of protein constituents in small nuclear ribonucleoproteins. 
Immunoprecipitation studies were carried out to analyze this question, 
utilizing human autoimmune sera shown to be reactive with these particles. 
Metabolic labeling was carried out on the human myeloid cell line K552 
35 . . . 
using S-methionme and incubating for 15 hours m RPMT 1^40 mediim made 
deficient in methionine. Immunoprecipitation was carried out using serum 
from a patient with SLE, displaying anti Sm serology as determined by 
75 
passive hemagglutination. S-methionine labeled cells were lysed 
hypotonically and nuclei extracted using 0.2 M NaCl. Post nuclear 
supernatent was immunoprecipitated by anti sm antibodies followed by 
Protein A Sepharose 4B, washing, elution, and SDS-polyacrylamide gel 
electrophoretic analysis. 
Figure 2 shows the pattern of precipitated ^^S-labeled peptides when 
anti Sm (lane 1) or normal human serum (lane 2) are used. The eight 
peptides labeled A-G migrate with mobility corresponding approximately to: 
A- 32,000 d 
B- 25,000 d 
B'- 25,000 d 
C- 19,000 d 
D- 15,000 d 
E- 12,000 d 
F- 11,000 d 

-17-
G- 8,000 d. 
Since the snRNP proteins reside in particles in vivo, it was felt to be 
likely that any nonantigenic snRNP peptides should be visualized following 
immunoprecipitation by virtue of coprecipitation phenomena (discussed 
further for the anti RNP serology in Chapter 3). The possibility that 
other snRNP peptides may show sensitivity, particularly to divalent cation 
concentrations has been tested under conditions of 5 mM MgCl^ and 25 mM 
EDTA revealing no apparent sensitivity of snRNP components to these agents 
(data not shown). 
In vitro Translation of SnRNP Proteins 
Further analysis of snRNP peptides was carried out by in vitro 
translation. RNA was extracted from ^5^*^ cells and the p»ly A+ fraction 
was translated using wheat germ cell-free extract. Immunoprecipitation of 
translation products is shown in Figure 3, All eight peptides were clearly 
seen from precipitates of poly A4- RNA translation products. Ttie poly A-
fraction (defined only by repeated passage over oligo dT cellulose) 
appeared to contain mRNAs for most of the peptides, although the 
possibility certainly exists that residual A+ RNA was present in this 
fraction. Relative decreases in A, B, and B' are seen as well, in products 
of total RNA translation. V̂ftiile it is difficult to accurately compare 
quantitative aspects of these different fractions, the presence of all 3 
snRNP peptides in the poly A+ translation is firmly evident. Furthermore, 
no gross changes in mobility are seen for any of the peptides relative to 
in vivo labeled snRNPs, an observation which has been made by runnirig in 




proteolytic Cleavage Patterns 
Preliminary experiments were carried out to study relatedness of the 
various snRNP peptides. protease cleavage was carried out with 
chymotrypsin and protease V^ to search for possible precursor-product 
relationships among the proteins. A typical experiment with such analysis 
is illustrated in Figure 4. Tn vivo S-methionine labeled, 
immunoprecipitated snRNP peptides A, B, B', and D were cut out of an SDS 
polyacrylamide gel (as in Figures 2 and 3) and subjected to proteolysis 
with chymotrypsin according to the method of Cleveland, (1977^Enzyme 
concentrations of 10, 1, and 0.1 ug per lane were used, as indicated. Ttie 
untreated peptides are seen to migrate essentially the same as in Figures 1 
and 2, with some differences due to the 20% polyacrylamide concentration 
used in the proteolysis gel (vs. 15% in other experiments) . Comparison of 
the cleavage patterns for these four peptides reveals no striking 
similarities. While occasional proteolytic fragments comigrate for 
different peptides, the vast majority of lytic products form migration 
patterns which appear to be unique for each protein. 
Fractionation of RNA Encoding snRNP Proteins 
To further study the possibility that precursor-product relationships 
exist among the 9n-precipitated snRNP proteins, size fractionation of poly 
A+ RNA was carried out prior to in vitro translation. If any two of the 
snRNP proteins are encoded by the same mRNA, but differ by post-
translational cleavage or processing, then their mRNAs should not be 
separable by size fractionation. K562 poly A+ RNA was fractionated on a 
10-30% sucrose gradient, each fraction was translated, and the products 
were immunoprecipitated with sm serum. Figure 5 shows such a fractionation 
experiment. Tn 5a, 3 ul of total translation products were analyzed 
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(without iimunoprecipitation) , Clear evidence appears for different sized 
proteins derived from the RNA gradient fractions. Figure 5b shows 
translation products immunoprecipitated using an sm serum. The eight Sm-
precipitable proteins are seen to be resolved into seven fractions. Ttie 
mRNAs for proteins A-G appear to migrate separately in the sucrose 
gradient. It is noteworthy that the peak fractions of mRNA for proteins B 
and B' are reversed relative to the sizes of the two proteins. Ttiese data 
suggest that the eight snRNP proteins are translated from separate mRNAs. 
Furthermore, it was observed that the sm serun was able to precipitate the 
eight labeled snRNP proteins in the absence of one another. 
DISCUSSION 
Immunoprecipitation coupled to cell free translation studies have been 
carried out to analyze the biochemical identity of snRNP proteins. Tine 
results have demonstrated that all ^ snRNp proteins defined by 
35 
precipitation from S-methionine labeled cells, can be translated m vitro 
and recognized by SLE sera. SDS-polyacrylamide gel electrophoretic 
migration revealed no apparent differences in mobility of the snRNP 
proteins generated in vitro and in vivo (Fig. 3) suggesting that major 
post-translational processing events either to not occur or have occured to 
completion in the translation system. Itie observation that the RNA's 
encoding the 3 proteins were separable discounts the possibility that these 
proteins are related as precursor-product. Ttie data suggest that eight 
separate mPNA's encode snRNP proteins A-G. Furthermore, the relative RNA 
sizes correspond to the protein molecular weights (as judged by sucrose 
gradient migration). The only exception is the mRNA for protein B* which 
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migrates as a larger RNA than that encoding B. Tn light of the very 
similar sizes of proteins B and B* as well as the appearance of only one 
"B" band following immunoprecipitation of rodent snRNP's fLerner and Steitz 
1979), it is of significance that they are translated from separate 
messages and are not variants of the same primary translation product. 
Chymotryptic peptides also clearly distinguish the proteins from one 
another (Figure 4). Ttie reports (Conner, et al., 1937; petterson, et al., 
193/1) that a monoclonal antibody is capable of recognizing proteins B and D 
is of related interest. While the possibility that these proteins are 
related as precursor-product appears unlikely, the sharing of antigenic 
determinants suggests the possibility of some relationship among these 
proteins at either the DNA or mRNA processing levels although no obvious 
shared proteolytic fragments were observed for these proteins (Figure 4). 
Shared determinants could suggest that a limited idiotype repertoire may be 
sufficient for recognition of the many snRNP proteins by autoimmune sera. 
Several groups have described an antigenic peptide of approximately 5**,000d 
thought to be contained in certain snRNP particles (Hinterberger, et al., 
1933; Kinlaw, et al., 1983; White and Hoch 1931). While larger peptides 
appear in immunoprecipitates and immunoblots with certain sera, screening 
in this laboratory of numerous MCTD and SLE sera has not revealed 
correlation of any particular high molecular weight band with either 5*n or 
RNP serology (Conner, et al., 1932). Antibodies against a nuclear matrix 
protein of approximately the same molecular weight have been described in 
many MCTD sera Habets, et al. (1983). Further studies regarding the 
identity and immunogenicity of these larger peptides are currently in 
progress, utilizing several recently generated monoclonal antibodies (W. 
Reeves, personal communication). Experiments in this laboratory have not 
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demonstrated the presence of any additional snRNP peptides in the range of 
15,000-33,OOOd (other than A-G), as reported by several other groups 
(Hinterberger, et al., 1933; Kinlaw, et al., 1933). While occasional 
immunoprecipitates have revealed such additional bands, comparison of total 
lysate proteins has generally revealed those species to correspond to very 
abundant cellular proteins. Lack of these bands in immunoprecipitates of 
in vitro translation products from size fractionated poly A-»- RNA (Figure 
5b) supports this notion. 
Figure 2 
Small Nuclear ribonucleoproteins recognized by Sm serum. S-methionine 
labeled K552 cells were lysed and immunoprecipitated using normal human 





In vitro translation of shRNP proteins. RNA from the K=̂ 52 cell line was 
extracted, and either translated directly (tot.) or fractionated into poly 
A+ (A-*-) and poly A~ (A~) fractions prior to translation using wheat germ 
cell free extract. Translation products were immuno precipitated with Sm 
serum. 











peptide mapping of ̂  snRNP peptides, peptides A, B, B*, and D were excised 
from a resolving SDS gel as gel slices, v*iich were placed into wells of a 
20% SDS-polyacrylamide gel and overlaid with chymotrypsin in loading buffer 
(either 0.1, 1, or 10 ug enzyme per lane as indicated). Samples receiving 
no enzyme are labeled "uncut." peptides were run into the stacking gel, 
allowed to digest at room temperature, and then resolved as described 
(Cleveland, et al., 19*^''). "I^e cleavage patterns do not resemble patterns 
predicted for post-translationally modified forms of the same peptide. 




Sucrose gradient fractionation of mRNAs encoding shRNP proteins. K562 poly 
A-i- RNA was fractionated on a 10-30% sucrose gradient and precipitated with 
ethanol, and each fraction was translated in a cell-free system. Figure 5a 
shows 3 ul aliquots of total translation products from each fraction. 
Figure 5b shofws sm immunoprecipitates of translation products from the 
fractions. Lane 1 represents the top of the gradient. 
B 
total products 
3 4 5 6 7 8 







Specificities of the snRNP reactive human autoantibodies, anti-Sm and anti-RNP 
ABSTRACT 
Antibodies directed against small nuclear ribonucleoprotein (snRNP^ 
particles are found in the sm and RNP autoimmune sera from numerous 
patients with systemic lupus erythematosus (SLE) and mixed connective 
tissue disease (MCTD). While these autoimmune sera contain snR^TP reactive 
antibodies, distinctions in antigen binding specificity have been difficult 
to define because of the particulate nature of the snRNP antigen. To 
overcome this problem, while obtaining the antigen in a native state, 
cell-free translation of poly A+ RNA was carried out. In addition, cells 
35 
were pulse labeled with S-methionine for 3 minutes to generate 
radioactive snRNP proteins in forms reflecting incomplete de novo particle 
assembly. Immunoprecipitation of snRNP antigen prepared in these manners 
revealed clearly distinct patterns of Sm and RNP immunorecognition. While 
sm sera precipitated all 3 labeled snRNP proteins, RNP antibodies 
precipitated only 2 of the eight. One of the proteins (the A protein) of 
32,OOOd was seen to lose antigenicity upon RNase treatment either when 
extracted from cells or when generated in vitro. RNase treatment of 
immunoprecipitated snRNP*s released the A protein in an electrophoretically 
pure form. Analysis of in vitro translated snRNP's has revealed the 
presence of both unassembled and assembled particles as determined by 
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sucrose density gradient sedimentation. Post-translational assembly of 
snRNP's involving both RNA-protein binding (as revealed by A protein 
antigenicity) and associations of other snRNP proteins occured in the in 
vitro system employed here. In addition to antibodies to the other 5 snRNP 
peptides, all Sm sera tested have been found to contain the RNP-like 
reactivity with snRNp proteins A and C. TVro patients were observed to 
switch with time from Shi to RNP-like snRNP recognition. Selective 
reactivity with A and C proteins is of particular interest because these 





The two serotypes which display reactivity with snRNPs are Sm and RNP. 
Ttiey have been distinguished by virtue of an apparent RNase sensitivity of 
the antigen recognized by RNP sera (Mattioli and Reichlin 1971; Sharp, et 
al., 1972; Northway and Tan 1972). Analysis of the protein constituents of 
snRNPs has resulted in differing, although likely compatible, reports on 
the precise components of these particles. In vitro translation studies 
(see Chapter 2) together with the reports (Hinterberger, et al., 1Q33; 
Kinlaw, et al., 1933) of nonimmunological snRNP particle purification have 
allowed at least 3 separately translated proteins to be identified as snRNP 
constituents. 
Identification of which species are specifically recognized by Sm and 
RNP serum antibodies has been plagued by difficulties related to the 
noncovalent interactions which hold snRNP particles together. 
Immunoprecipitation of endogenously labeled snRNPs has therefore been of 
limited value in delineating distinctions between peptide recognition by Sm 
and RNP sera. Detergent treatment and immunoblot (Western) analyses have 
revealed several differences in the serologies. However, identification of 
all antigenic peptides requires native undenatured proteins since most 
snRNP peptides are not recognized by SLE antibodies following exposure to 
denaturing detergents. 
Sm and RNP Antigen Recognition of snRNPs subjected to extended labeling 
Extended in vivo labeling of snRNPs was carried out by incubation of 
K552 cells for 15 hours in the presence of S-roethionine. Lysis and 
immunoprecipitation results in identification of the eight proteins A-G, 
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uniquely precipitated by both Sm and RNP sera, but not with normal human 
serum (Figure 5). Although various higher molecular weight bands have been 
seen as well, including several uniquely recognized by certain sera, these 
have not been correlated with either Sm or RNP serology (Conner, et al., 
1982). 
Sm and RNP recognition of Jri vitro generated snRNP proteins 
Previous work has indicated that bands A-G exist in complex particles 
which could be dissociated by mild detergent treatment during extraction of 
antigen from labeled cells (Conner, et al., 19^2). Furthermore, unique and 
distinguishable subsets of these eight proteins (from dissociated 
particles) are recognized by Sm and RNP sera, although detergent 
denaturation destroys reactivity with most of the proteins. As an 
alternative to particle disruption by detergents, incompletely assembled 
snRNP's might facilitate the analysis of Sm and RNP serological 
reactivities with native snRNP components. Such reactivities might be 
identified by immunoprecipitation of products from in vitro translation of 
snRNP peptides. Wheat germ extract (Erickson and Blobel 1^33) was utilized 
for in vitro translation of K^f^'> poly A+ RNA, followed by 
immunoprecipitation using an and RNP sera. Figure 7 shows typical results 
of such experiments. As with in vivo generated antigen (lane "»), Sn serum 
precipitates all eight proteins from translation products (lane 7), while 
RNP serum (lane 3) precipitates only proteins A arv3 C. Five different Sm 
and RNP sera gave similar results. Ttius markedly different patterns of Sm 
and RNP antigen recognition have been detected using cell-free translation 
products. Such unique patterns are not seen when antigen is prepared from 
cells which have been radioactively labeled for an extended period of time 
(Fig 5). Precipitation of all snRNP proteins by both sera using snRNP 
proteins labeled in vivo probably results from associated particle 
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precipitation by RNP serum, although only two proteins are being 
immunologically recognized. Analysis of unassociated proteins allows for 
more accurate determination of individual protein reactivities. 
In vitro particle Assembly 
From the data presented it was impossible to be certain whether the Sn 
sera used in these studies are recognizing each of the snRNP proteins 
independantly or precipitating all eight by virtue of narrow specificity 
and coprecipitation of proteins assembled into particles or particle 
precursors. Even in the RNA fractionation experiment (Figure 5) the 
possibility remained that each separate protein was associated with 
unlabeled proteins or snRNP particles present in the wheat germ extract 
system. To address this question, products of translation in vitro were 
subjected to sucrose gradient fractionation followed by immunoprecipitation 
with Sm serum. As shown in Figure 3, bands B-G are present in the first 
seven fractions, which represent sedimentation coefficients less than 75. 
Band C was seen in the top two fractions upon longer exposure of the gel 
(data not shown). Mature snRNPs have been reported to sediment at 
approximately 5-1 IS (Mattioli and Reichlin 1971; Northway and Tan i972; 
Howard 1973; Lerner and Steitz 1979). itie presence of these snRNP proteins 
in fractions of low S value suggests that the proteins are present as 
separate monomeric species, unassociated into complexes. On the basis of 
their immunoprecipitation in this form, it is apparent that 9n serum does 
contain antibodies capable of recognizing proteins B-G individually. The 
greater mobility of D relative to the other proteins is of some interest. 
It suggests either that D has associated with other species (e.g. protein 
or RNA) or that it has an unusual three-dimensional configuration 
accounting for its larger S value. In this regard it may be of related 
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interest that D protein appears to split into a doublet upon 
immunoprecipitation with certain sera (see below). Further examination of 
Figure 3 also reveals the presence of snRNP proteins in fractions of 
approximately 7 and 11S. Ttie presence of snRNP peptides in these fractions 
suggests that limited particle assembly is occuring during or subsequent to 
translation in vitro. Tlie finding that snRNP proteins are present in 
approximately 7S and US fractions is similar to previous observations 
(Mattioli and Reichlin 1971; Northway and Tan 1972; Howard 19*73; Lerner and 
Steitz 1979) that there are two size classes of snRNP particles. Although 
particle assembly can occur in the cell-free translation system, most snRNP 
proteins exist in unassembled form (Figure 3), a fact that allowed the 
distinction between Sm and RNP recognition (Figure 7), Nevertheless, the 
ability to generate assembled snRNPs in vitro may provide a means for 
analysis of the protein-protein and protein-RNA interactions that 
undoubtedly underlie the biological functions of these nuclear complexes. 
Recognition of pulse labeled shRNPs 
A second source of labeled snRNP proteins v^ich may represent 
incompletely assembled particles may be generated by brief pulse labeling 
of K552 cells with S-methionine, rather than labeling for an extended 
period of time. A titration experiment was performed in v^ich K552 cells 
were starved of methionine for various times prior to 3 minute pulse 
35 
labeling with S-methionine, extracting, and anti-Sm immunoprecipitation. 
As seen in Figure 9, only with some starvation were all eight peptides well 
labeled. itie selective absence of A protein is somewhat striking in the 
total absence of methionine starvation ("0 starvation") and may relate to 
the kinetics of A protein metabolism in K552 cells. All pulse-labeling 
experiments performed subsequently, made use of cells previously starved of 
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methionine for 0.2 to 2 hours. The results of anti-Sm and anti-RNP 
35 
immunoprecipitation following an eight minute pulse of S-methionine are 
shown in Figure 10. The three Shi sera shown (lanes 2, 3, and 7) 
precipitated all eight snRNP proteins, v^ile the three RNP sera (lanes 4, 
5, and 5) precipitated proteins A and C only. Normal human serum (lane 1) 
precipitated none of these proteins. Ttius, although all eight particle 
35 
proteins incorporate S-methionine during an eight minute pulse (as 
illustrated by their precipitation with the Sm sera) , only a subset of 
these proteins, bands A and C, are precipitable by RNP sera. Pulses as 
short as 2 minutes gave identical results (data not shown). Studies of 
over 20 Sm and RNP sera, including standards from other institutions 
demonstrated the same distinct Sm and RNP patterns of reactivity in all 
cases. Analysis of in vivo and in vitro synthesized snRNP proteins thus 
demonstrate the same distinguishable patterns of Sm and RNP antigen 
recognition. 
D Band Split 
In the process of analyzing snRNP recognition by numerous anti-Sm and 
anti-RNP sera, a reproducible split in the appearance of the D peptide was 
seen for certain sera, but not others. No correlation was seen with sm or 
RNP serology. Anti-RNP patients which displayed this splitting pattern 
lacked detectable antibodies to D as demonstrated by in vitro translation 
and pulse labeling of snRNP proteins. Figure 11 shows an example of such a 
split D pattern generated by immunoprecipitation of 15 hour labeled snRNPs 
with a certain RNP serum. Mi, (lane 2). An Shi serim, Tu, which displayed 
only a single protein is also seen (lane 1). While the possibility exists 
that one of these bands represents a non-snRNP species such as a histone 
(against which antibodies are sometimes found in SLE (Kunkel, et al. IPf^o, 
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Stollar, 1971), the comigration of both D bands at 10S in sucrose gradients 
(see Figure 17 , chapter 4) suggests that they are true snRNP components. 
Since antibody specificity is not likely to account for these varying 
patterns- because the RNP serum has no apparent antibodies to these 
peptides (Figures 7 and 10), the possibility exists that this splitting 
pattern represents a serum-specific modification of the antigen which 
occurs during immunoprecipitation. 
To test this possibility, the following experiment was performed. 
Fifteen hour labeled snRNPs were immunoprecipitated with two sera, one (Tul 
which gives a singlet, and the other (Mi) which gives a doublet D. 
Following adsorption of the immune complexes onto protein A Sepharose, the 
beads were washed extensively with detergent free buffer. Each set of 
beads was then incubated with cold (unlabeled) K552 cell lysate plus the 
other serum for 1 hour at 20^C. Samples were washed, eluted and analyzed 
electrophoretically. As can be seen in Figure 12a, mixing revealed that 
treatment of Tu immunoprecipitate with Mi serum plus lysate converted the 
single D into a doi±>let. Incubation of Tu serum plus lysate had no 
apparent effect on Mi immunoprecipitate \^ich still displayed a doublet. 
To test v^ether the activity giving rise to this splitting of D 
resides in the lysate or is entirely in serum, the above experiment was 
repeated using only serum in the post-immunoprecipitation mixing steps. 
Figure I2b shows that the splitting effect was still seen when only Mi 
serum diluted as before (in lysis buffer) was added to the Tu 
immunoprecipitate. When the second step was carried out with Mi serum 
pretreated with 1 ug/ml each of antipain, leupeptin, pepstatin (kindly 
provided by Dr. Reid Gilmore) , 5 nW iodoacetamide, and 0.5 mM 
phenylmethysulfonylfluoride, and mixing carried out at 4° C, splitting was 

-34-
still seen (data not shown) despite the presence of these protease 
inhibitors. While proteolysis cannot be firmly ruled out by these studies, 
the possibility remains that the faster migrating form of D protein is 
modified in a serim specific fashion, and this modification (or removal of 
a modifying group) may shed some light on the peptide's chemistry and 
function. 
A final possibly related point is the somewhat anomalous migration of 
unassembled (low S value) D protein, as seen in Figure 3 in products of in 
vitro translation of snRNPs. peptides of apparent larger molecular weight 
migrated slower in the sucrose gradient than the faster SDS-gel migrating D 
protein. The serum used in the experiment of Figure 3 recognizes a single 
D band. Ttie possibility therefore exists that the anomalous D peptide 
mobility in sucrose gradients may relate in some manner to the presence of 
a modification which is chemically altered specifically by an unidentified 
serum component in certain irx3ividuals. 
RNase treatment of snRNPs 
To examine the protein and RNA components responsible for 
immunorecognition by SLE sera, in vivo labeled and in vitro translated 
snRNP's were treated with RNase prior to immunoprecipitation. Lanes 1 and 
3 in Figure 13a demonstrate typical results of immunoprecipitation using 15 
hour in vivo labeled antigen, precipitated with RNP and Sm sera 
respectively. Bands A through G are all present in precipitates using both 
sera. RNase treatment of extracted cellular antigen prior to 
immunoprecipitation with RNP and Sm resulted in loss of A band (lanes 2 and 
4). Examples of immunoprecipitations of snRNP antigen derived from in 
vitro translation are shown for Sm and RNP sera in the absence (Figure 13b 
lanes 1 and 3) or presence (lanes 2 and 4) of RNase treatment. In contrast 
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to in vivo antigen analysis, precipitation of in vitro translated products 
gives unique patterns for Sm and RNP sera. In all cases, however, 
precipitation of the A protein is strikingly affected by RNase treatment. 
A higher molecular weight protein not known to be associated with snRNP's 
precipitated preferentially with RNp serum following RNase treatment 
(Figure 13b lane 4). 
In an attempt to recover nonantigenic, RNase treated A protein, in 
vivo labeled cell extracts were immunoprecipitated onto protein A Sepharose 
beads, followed by extensive washing of the beads and subsequent RNase 
treatment. Figure 13c shows RNase treated material which remained bound to 
the sepharose when precipitated with RNP or Sm (lanes 2 and ^). Loss of A 
protein again occured for kxjth sera. When the supernatents of the RNase 
treatments were run in adjacent lanes (lanes 1 and 3), band A is seen to be 
essentially the only labeled protein present. In separate experiments it 
was observed that this band migrated in the exact position of the A 
protein. 
RNase treatment of antigen has thus been shown to abrogate 
immunoprecipitation of the A protein. While RNP serology has been 
distinguished from sm by virtue of an RNase sensitive hemagglutination 
assay (Tan and Peebles 1975), it is significant that recognition of A 
protein by Sm serum is equally destroyed by RNase. Similar results have 
been obtained by using an ELISA for snRNPs (W. Reeves, personal 
communication). Thus, although RNP antibodies recognize only two of the 
eight 5^m-preci pi table proteins, 
Sm antibodies display an equal restriction in recognizing the A protein 
only in the context of an associated RNA. Tliese results are in agreement 
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with the report (W ieben, et al., 1933) that ui RNA increases antigenicity 
of in vitro translated A protein. It is uncertain, however, whether it is 
specifically Ui RNA that is responsible for the antigenicity of A protein 
seen in the RNA fractionation experiment (Fig. 5b). Any Ul RNA present in 
fractions 5 and 7 would exist despite oligo dT affinity chromatography and 
sucrose gradient fractionation, which was seen to have resolved the RNA's 
encoding snRNP proteins. While the possibility that trace Ul RNA is 
present in these fractions cannot be ruled out, alternative explanations 
exist. An RNA sp)ecies similar to Ul may be present in wheat germ extract 
and be responsible for antigenicity of A protein. If so, such a species 
may be revealing about comparative RNA binding specificity of A protein. 
•Hie possibility also exists that an entirely different RNA species is 
binding to A in these fractions. Ttie ability to generate 
electrophoretically pure native A protein (Fig 13) should facilitate 
further studies of its biochemical properties. 
Shift from Sm towards RNP recognition in two patients in the process of 
screening numerous patient sera for snRNP reactivity, using pulse labeled 
cell extract to distinguish sm and RNP, an unusual observation was made. 
TVo sera from the same patient which differed by several years appeared to 
generate different patterns of antigen recognition. Further analysis was 
carried out by immunoprecipitation analysis (of pulse labeled snRNPs) using 
sera from throughout the patient's disease course at the Rockefeller 
University Hospital. Results of such analysis are seen in Figure 14. 
While this patient produced a typical Sm pattern of precipitation in serum 
from 19'7P, a shift in reactivity was first detected to have occurred 
between 1979 and 1981. By June of 1932 the immunoprecipitation pattern is 
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almost a typical RNP pattern. Some clear evidence exists for B and B' in 
the immunoprecipitates indicating residual Shi reactivity, however the shift 
towards RNP-like recognition is quite striking. A similar shift was 
subsequently detected in a second patient (Figure 15). In this situation 
first evidence for loss of sm-specific reactivity began between August and 
October of 1930. Vfriile small quantities of Shi-specific bands appeared for 
about one and a half years (10/'30-3/'32), further loss of such reactivity 
continued in 1982. While the possibility is currently being investigated 
that these observed shifts may correlate with disease-related activities, 
these examples provide an illustration of the utility of such sensitive 
analytical methods in the analysis of disease conditions. 
DISCUSSION 
The previous inability to distinguish the fine nature of antigen 
recognition of sm sera from RNP sera is in large part due to the fact that 
snRNP antigens are complex particles. Antibody recognition of any 
component in the particle results in immunoprecipitation of the entire 
particle, itius when the antigen is radioactively labeled by prolonged 
35 
incubation with S-methionine, little if any difference has been seen in 
the patterns obtained with sm and RNP sera (Figure 5). Previous attempts 
to disrupt the particles using 0.5% SDS treatment have revealed 
differential recognition of several snRNP peptides by Shi and RNP sera 
(Conner, et al., 1932). Likewise using SDS gels and immunoblots, several 
of the snRNP peptides have been observed to be uniquely recognized by Sm 
and/or RNP sera and monoclonal antibodies (White and Hoch 1Q81; Conner, et 
al., 1982; Petterson, et al., 1934). However many of the peptides were not 
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recognized and the possibility remained that all snRNp peptides are 
antigenic but SDS treatment seriously alters antigenicity. 
For these reasons, the present study was initiated to analyze in vivo 
synthesized, native snRNP peptides. To circumvent the need for particle 
disruption or detergent treatment, the strategies involved in vitro 
35 
translation and brief pulse labeling with S-methionine. By these methods 
of analysis a clear distinction is seen between Sm and RNP serological 
immunorecognition (Figures 7 and 10). While sm sera precipitate all snRNP 
components, only two of these labeled peptides, A and C, appear in RNp 
immunoprecipitates. 
An understanding of the peptide antigen recognition by Sm and RNP sera 
is of considerable value in light of the common clinically used assays for 
these sera. While RNP reactivity has traditionally been distinguished from 
Sm by RNase sensitivity in hemagglutination and immunodiffusion assays 
(Northway and Tan 1972; Mattioli and Reichlin 1973), it is of interest that 
immunoprecipitation of RNase treated snRNP's produces an identical change 
in antigen recognition by the two sera. Loss of the A protein 
immunoprecipitation occurs for both Shi and RNP sera . W small nuclear 
RNA has been shown by Wieben, et. al. (1933) to be critical for A 
antigenicity. Ttius, the finding that RNP sera recognize only proteins A 
and C may help explain the biochemical basis for the hemagglutination assay 
since essentially only C protein reactivity remains for RNP sera in RNase 
treated snRNP's. For reasons of valency, 3-dimensional configuration, or 
chemical treatments of antigen, the C protein may be poorly reactive in 
snRNP particles, in agar diffusion plates (Mattioli and Reichlin 107i) or 
when attached chemically to red blood cells (Tan and Peebles 1975)-
particularly since the most common source of antigen is an acetone extract 

-"50-
of rabbit thymus. Antibody to C protein may poorly hemagglutinate or 
precipitate with antigen under these conditions. If C protein recognition 
is not predominant in these assays, then A protein antigenicity would be 
the critical recognition for RNP antibody induced hemagglutination or agar 
precipitin formation. RNase treatment of snRNP's, then, would be expected 
to abolish RNP reactivity. Sm serum's additional recognition of proteins 
B, B', D, E, F, and G, however, would still allow for Shi reactivity in 
these assays regardless of RNase. Ttiis interpretation is further supported 
by the observation that using an ELTSA assay, RNP recognition may be 
somewhat diminished, but is by no means abolished by pretreatment of 
snRNP's with RNase (W. Reeves, personal communication) . White and Hoch 
(1931) have also demonstrated RNP antigen recognition in the absence of 
associated RNA from rabbit thymus acetone extract. 
Several groups (Kinlaw, et al., 1933; Hinterberger, et al., 19^3) have 
reported the isolation of two classes of snRNP particles, one of which 
lacks proteins A and C. Tliis class contains the U2-5 small nuclear RNA 
species' while the particles containir*g proteins A and C contain Ul RNA. 
•Hie other 6 proteins (B, B', D, E, F, and G) are common to both classes of 
snRNPs. 
In light of the finding that RNP sera recognize proteins A and C only, 
while sm sera recognize all 3 components, early reports of the relationship 
between Sm and RNP antigens are better understood. Several groups 
(Mattioli and Reichlin 19*^1; Northway and Tan 1972; Sharp, et al., 19'^2) 
described RNP (also called "Mo") as an RNA containing antigen. However, 
fractionation experiments failed to separate it from Sm-reactive material. 
This was in contrast to the ability to fractionate pure Sm-reactive 
material away from RNP/Shi reactive antigen. Tlius, pure sm-reactive antigen 
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lik̂ 'ly corresponds to U2-5 containing snRNPs which contain 5 peptides, but 
lack A and C. Sm/RNP reactive antigen corresponds to U"!-containing snRNPs 
which react with RNP antibodies because of the unique presence in these 
particles of A protein (with its associated RNA) and C protein. An 
additional noteworthy observation concerns the finding that all an sera 
studied contain RNP-like reactivity, an observation v^ich has also been 
made by use of immunoblots by Petterson, et. al. (1934) and an ELISA assay 
(W. Reeves, personal communication). This clear presence of RNp-like 
antibodies in Sm sera raises questions regarding similarities and 
differences in the respective disease states. While the determinants on 
the A and C proteins recognized by the Sm and RNP antibodies could 
conceivably differ, it is striking that both sera lose reactivity with A 
after RNase treatment of antigen • Ttius at least one characteristic of 
the recognition is common to both sera. Relevant to this question is the 
observation of a temporal decrease in the Shi-specific antibodies in two SLE 
patients (see Figures 14 and 15). 
It is highly interesting that the two peptides (A and C) which 
distinguish these particle classes contain the precise antigenic 
determinants for RNP sera. Analysis of in vivo particle assembly has 
revealed a unique sequence of events v^ich further distinguishes A and C 
proteins in the kinetics of their incorporation into newly synthesized 
snRNP particles (chapter 5). Taken together, these considerations would 
suggest that the immunologic as well as parallel biochemical uniqueness of 
A and C proteins are not coincidental. 
Figure 5 
Sm and RNP sera immunoprecipitate the same radiolabeled peptides from 15-
hour, ^-methionine labeled cells. K552 cells were labeled in vivo with 
with ^^S-methionine for 15 hours, lysed, and the lysate was precipitated 





Comparison of Sm and RNP inmunoprecipitation of in vitro generated srtRNP 
proteins. 15 hour ^''s-methionine labeled K552 cell lysate was 
immunoprecipitated with Sm serum (lane 1). Tn vitro translation products 











Sucrose density sedimentation of native snRNP proteins translated in vitro. 
K552 poly A+ RNA was translated in vitro and total products were 
fractionated on a 5-20% sucrose gradient. Each fraction was 
immunoprecipitated with Sm serum and resolved on a slab gel. The pellet 
from the gradient centrifugation was resuspended and immunoprecipitated as 
well (lane P). The top of the gradient is indicated on the left. Relative 
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Titration of methionine starvation for pulse labeling of srtRNPs. K=i52 
cells were incubated in methionine free medium, and aliquots removed at the 
time points indicated (o to 3.25 hours). Such starved cells were then 
pulsed immediately with 500 uCi of S-methionine for 3 minutes. Pulse 
labeled cells were then lysed and immunoprecipitated with Sm serum. 
Hours Starvation 







Inmunoprecipitation of pulse-labeled snRNP proteins. K552 cells were 
•75 
starved of methionine and then pulse labeled for 3 minutes with S-
methionine. Following cell lysis, the snRNP proteins vere 
inmunopreci pita ted with normal human serim (lane 1), 3 different Sm sera 
(lanes 2, 3, and "7), and 3 different RNP sera (lanes ^-5). 
NHS Sm Sm RNP RNP RNP Sm 




Splitting of D band in Immunoprecipitates with certain sera. 15 hour 
labeled cell lysates were Immunoprecipitated with two sera. Serum from 
patient Tu immunoprecipitates a single D peptide, v*iile the precipitate 





Examination of D band splitting induced by sequential treatments with 
patient sera. Mixing experiments were carried out on immunoprecipitated 
snRNP peptides, adsorbed to protein A sepharose beads. A) Lanes i and 2 
show the doublet and singlet patterns of D protein, respectively. Lane 3 
contains products of immunoadsorbed, washed. Mi-serum precipitate further 
incubated with unlabeled K552 cell lysate plus Tu serum« Lane 4 shows the 
appearance of a doublet in Tu-immunoprecipitated D protein when further 
treated with lysate plus Mi serum. B) To test whether the splitting 
activity is present in the lysate or the serum, an experiment as in "A" was 
repeated, but with no lysate added in the second incubation. Lanes 1 and 2 
show treatment of precipitates with the same serum. Lanes "^ and 4 show 
incubations with the opposite sera. D splitting is observed by serum 
incubation alone. 
Serum 4-Lysate 
m Ttt +!• +li 
® 
1 2 3 4 
Serum 
Tup Mi-p Tup Mi-p 
+Tu +Tu +mi +Mi 




RNase treatment of in vivo and in vitro generated snRNP's. K552 cells (A 
and C) were grown in S-methionine containing medium for 15 hours followed 
by lysis and extraction. (A) Incubation at 3'7°c in the presence (lanes 2 
and 4) or absence (lanes 1 and 3) of 1mg/ml RNase A was followed by 
immunoprecipitation using RNP (lanes 1 and '>) or Sm (lanes *» and 4) sera. 
(B) Translation products of K552 poly A+ RNA were incubated at 25 C for 15 
minutes in the presence (lanes 2 and A) or absence (lanes 1 and 3) of 150 
ug/ml RNase A followed by immunoprecipitation using Sm (lanes i and 2) or 
RNP (lanes 3 and 4) sera. (C) Extract derived from 15 hour labeled K'^'^'' 
cells was immunoprecipitated onto SPA beads using RNP or Fin sera. 
Following 4 washes, the beads were incubated at 37 c with Img/ml RNase A. 
Supernatents were removed and beads were washed further. Bound proteins 
were eluted and analyzed on a slab gel. Lanes 2 and 4 show material 
remaining bound to the SPA beads after RNase incubation for RNP and Sm 
coated beads, respectively. RNase treatment supernatents showing a single 
A band appear in lanes 1 and 3 for RNP and Sm immunoprecipitations 
respectively. The lines at the side of each experiment show the positions 
of the A-G bands. 
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Change with time in Sm vs. RNP pattern of snRNP recognition in serim from 
an individual patient. Sera from IP^q through June 10R2 (5/P2) from a 
patient with SLE were used to immunoprecipitate snRNPs from pulse labeled 
K552 cell extract. A loss of Sm specific bands appears starting between 






Serial changes in snRNP recognition by sera from a second patient. Sera 
from February 1977 through July 19^2 were tested for snRNP peptide 
recognition usirq pulse labeled K552 cell lysate. An abrupt decrease in 9n 
specific reactivity occurred between R/f^O and 10/RO. 
1 9 8 2 — • 
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In vivo Synthesis and Assembly of SriRNPs 
ABSTRACT 
The in vivo synthesis and assembly of human small nuclear 
ribonucleoproteins (snRNPs) have been studied by use of pulse/chase 
analysis. Antibodies derived from patients with systemic lupus 
erythematosus (SLE) and mixed connective tissue disease (MCTD) recognize 
distinguishable subsets of pulse labeled snRNP peptides. Ttiese antibodies 
were used to immunoprecipitate sucrose gradient fractionated pulse-labeled 
and pulse/chased snRNP proteins. The results indicate that assembly of the 
anti-RNP reactive (Ul) snRNP is a two-step process involving prior assembly 
of a 5S core particle. Furthermore, a post-translational modification of 
one of the lOS snRNP specific peptides has been observed, and the kinetics 
of this process indicate that the modification occurs after particle 
assembly. Functional and structural implications of a protein core for 




Immunoprecipitation of Pulse/chased snRNPs. 
To explore in vivo events in the assembly of snRNPs, pulse-chase 
analysis of snRNp biosynthesis was undertaken. K552 cells were pulse 
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labeled for 8 minutes in S-methionme and then resuspended in complete 
medium (containing nonradioactive methionine). Ttiroughout further 
incubation, aliquots of jxilse/chased cells were removed at 0, 0.2, 1, 5, 
and 15 hours of chase. Cells from each time point were lysed and snRNPs 
were extracted. Following centrifugation to remove insoluble nuclear 
material, the extract was subjected to immunoprecipitation by anti-Sm and 
anti-RNP antibodies, derived from sera of patients with SLE and MCTD, 
respectively. The results of such pulse-chase analysis are illustrated in 
Figure 15. 
Directly following pulse labeling (0 chase), anti-Sm antibodies 
precipitate all 8 peptides A-G, while anti-RNP antibodies precipitate 
labeled snRNP proteins A and C only. Following increased periods of chase 
the pattern of proteins precipitated by anti-Sm remains essentially the 
same; all eight peptides are precipitated throughout the chase periods. 
Anti-RNP antibodies, however, are seen to coprecipitate all eight labeled 
peptides only after several hours of cold chase. By f> hours, clear 
evidence exists of bands B and B*, and by 15 hours all R peptides are 
visualized. Ttiis eventual coprecipitation of all snRNP particle components 
by RNP antibodies suggests that de novo snRNP particle assembly occurs in 
the time-course of such p)ulse/chase experiments. 
Sucrose gradient fractionation of pulse/chased snRNPs. 
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Since de novo assembly appears to occur within these 15 hours, 
analysis of this process was undertaken utilizing sucrose gradient 
centrifugation. K552 cells were pulse labeled or pulse labeled and cold 
chased for 15 hours. Tliese two cell sources ("pulse" and "chase") were 
lysed, and their snRNPs extracted as above. The extracts were loaded onto 
5-20% sucrose gradients and subjected to centrifugation for 20 hours at 
41,000 rpm in an SW50.1 rotor. Gradients were then fractionated, and each 
fraction was immunoprecipitated using anti-Sm and anti-RNP antibodies. Ttie 
four immunoprecipitation patterns generated by this analysis are shown in 
Figure 17. 
Anti-RNP immunoprecipitation of "pulse" gradient-fractionated extract 
is shown in Figure 17- "Pulse-RNP." Of the snRNP proteins, only 
radiolabeled A and C appear. A small amount of C protein is present near 
the top of the gradient migrating with sedimentation of less than 4S, and 
proteins A and C are both present in fractions of approximately lOS. This 
pattern suggests that immediately following an 9 minute pulse some of the 
newly synthesized C protein exists in an uncomplexed form (<4S) while some 
35 
newly synthesized C protein also exists in a complex ("lOS) in which S-
labeled A protein is also present. A complex containing all 8 snRNP 
proteins with similar mobility has been observed in products of in vitro 
translated snRNP proteins (see Figure 8, chapter 3). Itie presence of U., 
RNA in a lOS particle has also been reported (Lerner, et al., 1980). 
The pattern obtained from pulse gradient fractionated extract 
immunoprecipitated with anti-Sm antibodies is shown in Figure 1*7- "pulse-
Sm." As with anti-RNP antibodies, following pulse, C protein is present 
primarily in two forms, one of <4q , the other of about lOS. Radioactive A 
protein is again seen in the lOS fractions suggesting that this higher 
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mobility form of A and C is due to the presence of a complex in those 
fractions. In contrast to the anti-RNP patterns, however, an additional 
form of snRNP proteins is present in the anti-Sm immunoprecipitates. in 
the fractions of approximately 5S, snRNP proteins D, E, F, and a are 
clearly present. Ttieir coincident sedimentation rate suggests that these 
peptides also reside in a complex of about 5S. A similar snRNP complex 
containing these same peptides has also been observed in products of in 
vitro translated snRNP proteins (Figure 8, chapter 3; the appearance of A 
protein in 5-''S fractions in Figure 8 probably does not reflect its 
presence in a snRNP particle because RNP immunoprecipitation of such in 
vitro translation gradients reveals A protein alone in the same 5-7s 
fractions). Anti-RNP antibodies appear to lack reactivity with peptides 
other than A and C, v^ich explains absence of the 5S complex in Figure 14-
"pulse-RNP." The bottom fraction in Figure 14- "pulse-Sm" contains a band 
(see asterisk) of uncertain identity with mobility somewhat greater than 
the D peptide. 
Analysis of fractionated "chase" cell extract immunoprecipitated with 
anti-RNP is seen in Figure 14- "chase-RNP." The C protein is again seen to 
•^5 
be present in the upper two fractions (<45). Additionally, all eight s-
labeled snRNP particle proteins (A-G) are seen in fractions (10S) 
corresponding identically to those in Figure 14- "pulse-RNP" which contain 
labeled peptides A and C only. The identical migration of these "pulse" 
and "chase" lOS fractions suggests that the same eight proteins are present 
in each case, although only A and C are present in labeled form following 
brief pulse, of additional interest is the presence of 2 high molecular 
weight proteins (greater than 50 kd) near the bottom of the gradient (see 
arrows). While likely antigenic for the serum used here, they appear to be 
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distinct from snRNPS and migrate broadly as a complex of >10S. 
Anti-Sm immunoprecipitation of fractionated chase lysate is shown in 
Figure 14- "chase-Sm." Some C protein is again seen in the top two 
fractions with a sedimentation rate of <4S. While bands D, E, F, and C, 
are present in the "^S fraction (as in the "pulse" lysate, see Figure 14-
"pulse-Sm") , the lOS snRNP complex is seen to contain all 8 snRNP proteins 
in labeled form. No additional labeled peptides appear in the "lOS 
fractions which contain snRNP proteins A-G. Ttie presence of all eight 
labeled snRNP peptides in the lOS fraction suggests that particle assembly 
has occured since the pulse analysis, in which peptides A and C were the 
only labeled sp>ecies which migrated at lOS. 
Post-translational modification of C protein. 
An additional observation relates to the mobility of C protein after 
pulse and chase. Comparison of the 15 hour chase an lane with the 0 chase 
RNP lane (Figure 15, see arrows) reveals a distinct change in C peptide 
mobility. Immediately following pulse, the peptide has a greater mobility 
than after chase with evidence for a shift in mobility present within 1 
hour of cold chase. The shift appears to be complete by six hours. When 
pHilsed material is compared to the 15 hour chase, R^ analysis would suggest 
a shift in mobility corresponding to approximately 1000 d. preliminary 
39 
attempts at analysis of this modification did not demonstrate P 
incorporation following ^^^p-orthophosphate labeling of K552 cells and 0.1 M 
NaOH incubation of washed immunoprecipitates did not appear to alter the 
modified C protein (data not shown). 
Changes in D protein. 
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Of further relevance is the appearance in Figure 14- "chase-RNP" of D 
band as a doublet. Sera from certain patients have consistently given this 
pattern of two D bands, while others have not. Figure 14 illustrates the 
observation that both of the split D bands are intrinsic snRNp components. 
Implications of this split pattern were discussed further in Chapter "^. 
Cell fractionation and snRNP assembly. 
In an attempt to analyze aspects of the cellular localization of snRNp 
particle assembly, pulsed and pulse/chased cells were subjected to 
fractionation. The two types of labeled cells were lysed in hypotonic 
buffer, nuclei were pelleted by centrifugation, and the cytosol fractions 
were removed. Ttie nuclear pellet was extracted with 0.2 M NaCl. Labeled 
snRNP proteins in the cytosol and the nuclear extract were 
immunoprecipitated using anti-Sm and anti-RNP. Anti-Sm precipitates all P 
labeled peptides from cytoplasmic fractions of both pulsed and pulse/chased 
cells (Figure 18, lanes 1 and 2). Anti-Sm precipitation of nuclear 
fractions, however, reveals only labeled A and C peptides following pulse 
(Figure 18, lane 3), but again all eight peptides following chase (Figure 
18, lane 4), Anti-RNP precipitates contain only labeled A and C from 
pulsed cytoplasmic and nuclear fractions (Figure 18, lanes ^ and 7), v^iile 
all 8 snRNP peptides are precipitated by anti-RNP following chase- both in 
cytoplasmic (lane 5) and nuclear (lane «) fractions. The observations from 
Figure 17 suggests that pulse labeled A and C proteins reside together in a 
~10S particle containing the other unlabeled preexisting snRNP proteins. 
The results illustrated in Figure 18 demonstrate that pulse labeled A and C 
can be seen in cytoplasmic fractions where other snRNP peptides reside 
(presumably as a ~5S form- see Figure 17). However the pulse labeled 
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nuclear fraction contains A and C as the only radiolabeled snRNo species. 
Since these peptides reside in a "lOS form (the presence of <'̂ S C peptide 
is uncertain in the nucleus) , these results suggest that after a brief 
pulse, snRNP proteins A and C have assembled together with the other 
unlabeled snRNP species into a lOS particle some of which is present in the 
cytoplasmic fraction, but a good deal of which can be found in the nucleus. 
Finally, Figure 18 again illustrates the presence of a post-translational 
modification of C protein. The changing mobility of C peptide with pulse 
and chase is quite evident. Nuclear versus cytoplasmic origin of the C 
protein appears not to correlate with the presence or absence of the 
modification. 
DISOJSSION 
Three forms of snRNP proteins. 
While problems related to coprecipitation have hampered analysis of 
immunologic specificity using autoimmune sera, this same property has been 
of great value in studying assembly of the snRNP particles. Sucrose 
gradient analysis of snRNP's incubated for 15 hours after a brief pulse 
reveals labeled snRNP proteins in three recoverable forms from within the 
cell. The three forms are <4S, ~5S, and ""lOS (Figure 17). The 10S form 
appears to represent a mature snRNP particle characterized by others 
(Lerner, et al., 1980; Hinterberger, et al., 1903; Kinlaw, et al., 1983) 
and demonstrated to contain Ul RNA. The 5S fractions may include particles 
which contain the other U series RNA's (U2, U4, U5, and U5), based on 
purification and characterization of this second class of snRNp particles 
by Hinterberger, et al. (1Q83) and Kinlaw, et al. (1^83). proteins n, E, 
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F, and G are clearly present in the 5S particles. Peptides B and B', while 
not visualized here, have been suggested to reside in the U2, U^, U5, and 
U5 snRNP fraction. The third form of snRNP proteins found in vivo 
sediments at a low S value and likely represents unassembled snRNP protein. 
Only the C protein is seen in this form. Since A protein antigenicity is 
lost (Figure i"^. Chapter 3) (Wieben, et al., 1983) or greatly reduced 
(Petterson, et al., 1984) in the absence of U1 RNA, it is uncertain whether 
significant quantities of this peptide exist in unassembled form within the 
cell since they may not be precipitated by these antibodies. However, no 
significant quantities of unassembled (low S value) B, B', D, E, F, and G 
proteins were recoverable from K552 cells (Figure 17). Under comparable 
biochemical conditions, such low S value forms of proteins B-G were all 
recoverable from in vitro translated snRNP proteins (Figure 8, Chapter '^), 
suggesting that the peptides other than C protein would not have been 
missed due to instability or lack of antigenicity in the unassembled state. 
Sucrose gradient analysis of in vivo pulse labeled snRNPs (Figure i"') 
has also revealed three forms of these peptides. 1t»e <4S and •'5S forms 
appear indistinguishable from the snRNP's after a 15 hour pulse/chase. 
However, the third fraction which has identical mobility to the lOS chase 
fraction, contains only proteins A and C in labeled form. Most of the 
other snRNP proteins (D, E, F, and G) all of which are recognized 
individually by anti-Sm antibodies, reside only in the "5S fractions 
immediately following pulse labeling. Ttiese labeled proteins appear in the 
10S particle, however, following cold chase incubation. On the basis of 
their identical sedimentation rate, it appears likely that the two lOS 
snRNP fractions (pulse and chase- derived) are actually the same with 
regard to protein (and RNA) composition. Only A and C are present in 
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radiolabeled form following brief pulse. It therefore appears that while 
the other snRNP peptides are assembled into smaller particles (~5S), 
proteins A and C have associated with these other components in unlabeled 
form. Since the only other identified state of these proteins is a "'5s 
particle (Figure 17), it appears likely that newly translated proteins A 
and C associate with a preformed ~5S particle containing the other peptides 
found eventually in the "lOS snRNP. 
Two-step model of Ul-snRNP assembly. Taken together, these data imply 
an ordered sequence of events in the biosynthesis and assembly of snRNPs. 
These events involve the formation of a ~5S particle which is modified 
further to become a lOS particle (Figure 19). By this model, newly 
translated snRNP proteins are assembled into a 5S "core" particle prior to 
the addition of proteins A and C- which is associated with transformation 
into the lOS particle. 
This two step assembly process is based entirely on analysis of 
protein constituents of snRNPs. However, based on studies by Lerner, et 
al., 1980, Hinterberger, et al., (1983), and Kinlaw, et al., (1^83), 
certain correlations of these patterns with RNA components can be proposed. 
TVo sets of snRNP fractions with similar protein compositions to the 5S and 
lOS particles described here have been isolated by these groups and shown 
to differ in RNA content. Ttie lOS snRNP particle has been demonstrated 
previously (Lerner, et al., 1980) to contain Ul RNA. particles similar in 
protein composition to the 5S particle contain Û r Û r ^c,' ̂ ^ "^ small 
nuclear RNAs. Antigenicity of the A protein appears to require associated 
Ul RNA (Wieben, et al., 1983), and RNase treatment releases the peptide 
from snRNP particles (Figure 13, Chapter 3). In light of these results, it 
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is very likely that the assembly of the los snRNP (where A protein is 
clearly seen) from the 5S core involves Ul RNA addition as well as the 
presence of A and C proteins. It is unclear v^ether the 5c; core v^ich 
serves as precursor to the lOS snRNP contains U2, U-fl, U5, or U5 RNA's or is 
an RNA-free protein particle. TV/o proposed schemes for such assembly are 
shown diagramatically in Figure "^O. While the sucrose gradient analysis 
employed in this study would not distinguish 5S particles which lack RNA 
from those which contain RNA (if both populations were present, together), 
ion exchange chromatography has recently suggested the presence of 2 pl-
distinguishable populations of particles with protein composition similar 
to that of the 5S fraction in Figure 17 (data not shown) . Such an RNA-free 
core might also serve as precursor to the non-Ul snRNPs, by the addition of 
the respective RNA species'. Kinlaw, et al. (1983) and Mimori, et al. 
(1984) have described at least one peptide thoi^ht to be unique to U2-
containing snRNPs. If all snRNP assembly proceeds via a 5S core precursor, 
then the addition of U2, U4, U5, and U5 RNAs would occur together with the 
addition of any of these non-Ul snRNP specific proteins. If the core 
precursors contain any or all of the U^ ^ species, transformation to the 
lOS snRNP would require loss of U^_^ RNA as well as addition of U. RNA, and 
the A and C proteins. 
The results of cellular fractionation studies (Figure 15) are 
consistent with several reports (Elcieri, 1974; Zieve and Penman, 1975; 
Elcieri, 1980; DeRobertis, et al., 1982; Madore, et al., 1984) which 
suggest that assembly of the Ul-snRNPs occurs in the cytoplasm. By these 
proposals, precursors to the mature Ul RNA species are transported to the 
cytoplasm where further processing and presumably ribonucleoprotein 
assembly occurs. Ttie presence of labeled A and C proteins in the 
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cytoplasmic fraction of pulsed cells (Figure lo, lane i) is consistent with 
the notion that these represent newly assembled lOS particles which have 
not yet migrated to the nucleus. Some of the newly formed lOS snRNP is 
also found in the nucleus following pulse (Figure 1«, lane 3) consistent 
with rapid assembly and transport. However, it should be noted that all 
cellular fractionation experiments may be complicated by leakage between 
compartments during the fractionation procedures (Scheele, et al., 1Q78). 
The above fractionation data are consistent with cytoplasmic assembly, 
35 
particularly because the S-labeled A and C peptides are already seen in 
the nuclear extract (as well as cytoplasmic) following pulse. Nonetheless, 
all other possible assembly routes can not be excluded from these data. 
Several additional important aspects of this assembly process remain 
to be understood. A 5*^,000 d protein reported to be associated with the Ul 
snRNP (White and Hoch, 1981; Hinterberger, et al., 1983, Kinlaw, et al., 
1983) has not been visualized in these experiments. Ttjis protein has been 
inconsistently and nonquantitatively seen by immunoprecipitation (Kinlaw, 
et al., 1982). An anti-RNP monoclonal antibody (Billings, et al., 1Q82) 
recognizes a doublet near 58,000d. A high molecular weight doublet 
probably distinct from that one is seen by immunoprecipitation using the 
anti-RNP serum shown in Figure 17- "chase-RNP." Ttiese same peptides are 
also recognized by certain Sm sera while many anti-RNP sera lack the 
reactivity (Conner, et al. 1982). Ttie monoclonal antibody of Billings, et 
al. (1982) also recognizes a smaller peptide which may account in part for 
its snRNP recognition. Ttie 58,000 d peptide may associate transiently into 
snRNP particles (Kinlaw, et al., 1982), accounting for the difficulty in 
reproducibly immunopreci pi tat ing it. Further analysis of this and other 
high molecular weight antigens will be of great interest in further 
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elucidating structure and function of snRNPs and other antigen-autoantibody 
systems. 
Several implications may follow from the observation of two step snRNP 
assembly. The possibility exists that the modifications of the core 
precursor which convert it into the mature lOS snRNP comprise the addition 
of regulatory and/or specificity elements. One example of such a core-
containing multisubunit species is the highly regulated RNA polymerase 
complex in e. coli (Chamberlin, 1974). By analogy, the addition of several 
peptides and ui RNA to the snRNP core precursor may confer regulatory or 
specificity functions resulting in specific enzymatic activities, the best 
studied being RNA splicing (Lerner, et al., 1980). Based on their protein 
compositions (Hinterberger, et al., 1983; Kinlaw, et al., 1983) the non-Ul 
snRNP particles appear likely to contain a similar protein core. "rf an 
RNA-free protein core serves as precursor to all classes of U-RNA 
containing snRNPs, the addition of other proteins and a specific RNA moiety 
would be of paramount importance in determining any functional properties 
of the particles. An intrinsic catalytic activity of the RNA such as 
described in the tRNA processing species RNase P (Guerrier-Takada, et al., 
1983) might explain in part the apparent specificity of only the Ul 
containing snRNPs for mRNA precursor splicing events (Yang, et al., 19<^1; 
Padgett, et al., 1983). 
In relation to the autoantibody specificity of SLE and MCTD patients 
it is of interest that a striking feature v*iich distinguishes the Sm and 
RNP serologies is their nonexclusive versus exclusive recognition and 
immunoprecipitation of proteins A and C from among all the snRNP proteins. 
While sm sera bind components of the core precursor as well as proteins A 
and c, RNP sera lack any core particle reactivity (see Figure 17). itiese 
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differences in core pjarticle recognition may correlate with differences in 
SLE and MCTD disease manifestations. Perhaps some unique aspect of the 
state of these snRNp peptides within the cell relates to their unusual 
recognition by the immune system in disease states. 
A final set of observations is the discovery of a post-translational 
modification of the C protein and an uncharacterized modification in D 
protein mobility which occurs in a serum specific fashion. The splitting 
of D protein which is observed following immunoprecipitation with some, but 
not other anti-snRNP sera, likely relates to an integral snRMp particle 
component (Figure 17). This shift in mobility may be the result of the 
addition or removal of some chemical moiety frcxn the D peptide during the 
immunoprecipitation process. Ttie nature of the moiety remains to be 
determined. 
Ttie other observed snRNP modification involves a shift in mobility of 
de novo synthesized C protein as revealed by pulse/chase analysis. While 
R^ analysis would suggest a modification corresponding to "looo d, the 
possibility remains that, based on charge properties, the modification may 
be much larger or smaller (Weber and Osborn, 1975). An intriguing aspect 
of this change in C protein is the observation that based on pulse/chase 
analysis, the modification appears to occur after the C protein (or at 
least some fraction of it) has been incorporated into the lOS snRNP 
particle. In this regard, it is of further interest that some labeled C 
protein is present in unassembled form following 15 hours of cold chase. 
Since this form is likely to contain the modification (all C appears to be 
modified in Figure 15) , the possibility exists that the unassembled, 
labeled C protein in chase extracts is material once contained in the 10S 
particle. As such, this peptide may be capable of particle dissociations 
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and reassociations, again reminiscent of a class of factors represented by 
rho and sigma and their regulatory functions for the core enzyme of RNA 
polymerase (Chamberlin, 1974). Further understanding of the chemical 
nature of this modification may help elucidate functionally important snRNP 
properties. 
Figure 15 
SnRNP assembly as revealed by pulse chase time course. K5^2 cells were 
pulse labeled with S-methionine for 8 minutes. To chase, the pulse 
labeled cells were resuspended in medium containing unlabeled methionine. 
Aliquots were removed at 0, 0.2, 1, ^, and 15 hours of cold chase, snRNPs 
were extracted and immunoprecipitated using anti-Sm and anti-RNP autoimmune 
antibodies, as indicated. Ttie two arrows point out a post-translational 





Sucrose gradient analysis of pulse and pulse/chased snRNPs reveals £ 2 step 
assembly process. "Pulse-RNP") 8 minute S-methionine pulse labeled K'=i52 
cells were extracted and their snRNps fractionated on a 5-20% sucrose 
gradient. Fractions were immunoprecipitated using anti-RNP antibodies and 
protein A sepharose, followed by elution and resolution by SDS-
polyacrylamide gel electrophoresis. Standards for the sucrose gradient are 
human hemoglobin (>'.2S), IgG (7S) , and catalase (US). Ttie direction of 
the gradient (top to bottom) is indicated as left to right. Ttie snRNP 
peptides A and C are indicated in the margins. "Pulse-Sm") Aliquots of the 
same fractions used in "Pulse-RNP" were immunoprecipitated using anti-^^ 
antibodies and analyzed by SDS-polyacrylamide gel electrophoresis. 
35 
Proteins A-G are identified in the margins. "Chase RNP") 8 minute S-
methionine pulse labeled K552 cells were subjected to 15 hours cold 
methionine chase at 37°C. Such cells were extracted and their snRNPs 
fractionated on a 5-20% sucrose gradient in parallel to the gradients shown 
in "pulse-Sm and RNP." Fractions were immunoprecipitated using anti-RNP 
antibodies and resolved by SDS-polyacrylamide gel electrophoresis. 
"Chase-Sm" ) Aliquots of the same fractions used in "Chase-RNP" were 
immunoprecipitated with anti-Sm antibodies and resolved by SDS-





Newly assembled lOS SORNP is localized in the nucleus. Pulsed K552 cells 
(P) and pulse/chased cells (C) were fractionated by hypotonic lysis (as 
described in exp>erimental procedures). SnRNPs derived from nuclear (Nir) 
and cytoplasmic (CYT) fractions were immunoprecipitated with anti-Sm and 
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Figure IQ 
Scheme for assembly of the protein constituents of the lOS (Ul) snRNP. 
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Towards Isolation of cDNA clones for snRNP Proteins 
ABSTRACT 
An expression vector library has been constructed in the bacteriophage 
lambda gtll. RNA was derived frcxn the human cell line 2°"^, which expresses 
snRNP proteins similarly to other studied cells. The library contains 40% 
5 
recombinants and contains 1.75 X 10 recombinant m€mh>ers. Preliminary 
screening using anti-Sm serum of 250,000 such recombinants revealed ^4 
prospective candidates, nine of which were still positive on secondary 
screening. Further analysis of these clones may provide isolates of CDN'A 
clones for the snRNP proteins. 
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RESULTS AND DISCUSSION 
A Strategy has been devised for isolating cDNA clones encoding the 
various snRNP proteins. Ttie system of choice was bacteriophage lambda gtll 
(Young and Davis 1983). Ttiis vector offers the opportunity to screen for 
the desired clone with antibodies, because the insertion site is within the 
B-galactosidase gene- an inducible gene in e. coli. Ttie method for 
generating a library and screening is presented in materials and methods, 
however a brief description will be given here. 
Twice poly A+ selected RNA from the human tumor cell line 2^3 
(prescreened for snRNP expression by immunoprecipitation) , was reverse 
transcribed followed by second strand synthesis, linker ligation, and 
ligation into Eco Rl cut lambda gtll DNA. The insert-containing phage DNA 
was packaged into phage particles followed by infection of e. coli. Ttne 
bacterial strain used for screening contains lac deletions so that there is 
no background of B-galactosidase synthesis. Plating out a recombinant 
lambda gtll library on lac" bacteria in the presence of X-gal generates 
blue and colorless plaques. The blue plaques retain intact B-galactosidase 
and likely represent ligation of lambda arms back to each other. The 
colorless plaques, however, likely represent recombinants in which a cDNA 
has ligated to the lambda DNA (within the B-galactosidase gene). Ttie cDNA 
effectively interrupts the B-qalactosidase gene preventing its 
corresponding enzymatic action on the substrate analogue X-gal. Ttie 2Q3 
library obtained by these procedures contains -^0% cx>lorless plaques 
(corresponding to 40% recombinants). Ttie library contains a total of 1.75 
5 
X 10 such recombinants. 
Expression vector screening in lambda gtll contains several useful 
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properties relative to other expression vector systems. Being a 
bacteriophage, one generates plaques by infection rather than transfection 
(for plasmid vectors). Infection is generally at least an order of 
magnitude more efficient and thus larger libraries are usually obtained 
with phage vectors. The lambda gtll phage in particular has an aspect of 
its screening designed to circimvent a potential hazard in expression 
vector cloning. Expression of a hybrid protein (B-galactosidase 
interrupted by the cDNA) may on occasion be toxic to the infected bacterial 
cell- preventing the formation of a screenable plaque and effectively 
leading to loss of that particular clone. To screen lambda gtll, a 
bacterial strain Y1090 is used, containing a plasmid which expresses the 
lac Iq gene which acts as repressor for B-galactosidase operon- effectively 
blocking synthesis of any hybrid (and possibly toxici proteins. After 
plaques have grown for several hours, nitrocellulose filters presoaked in 
IPTG are overlaid onto the plate. IPTG binds the repressor, leading to 
derepression, or expression of B-galactosidase plus any inserts. After 
several hours of further incubation, any hybrid protein should have been 
synthesized and some should be bound in replica form to the nitrocellulose 
1 25 
filter. Ttie filter is then screened with antibcyiy and ' T-protein A, and 
any positive plaques are further studied. 
Screening was carried out for approximately 250,000 colorless plaques. 
Forty four areas were picked from primary screens and following secondary 
screening nine possibilities remain. Ttie very low nimber of prospective 
positives likely relates to the fact that only one out of six recombinants 
could be expected to have ligated in both the correct reading frame and 
orientation for proper expression. An additional c:oncern in relation to 
the snRNP proteins, is that antigenicity of most of these peptides is quite 
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sensitive to denaturation (most snRNP peptides are not seen on Western 
blots- using these same anti-Sm or RNP sera). While not complete, these 
studies may provide first steps towards isolation of cDNA clones of snRNP 
proteins. 
Chapter 5 
Summary and discussion: SLE and autoimmunity- a proposal 
Analysis of the antigens reccygnized by the f^ and RNP sera seen in 
autoimmune disease have suggested the following. Ttiese small nuclear 
ribonucleoprotein particles consist of two classes- one containing W RNA 
in association with 8 proteins (A-G), the other lacking proteins A and C 
while presumably containing U2, U4, U5, and U5 RNAs. Only the Ul snR^TP is 
recognized by anti-RNP serum antibcx5ies, because these antibodies recognize 
snRNP proteins A and C only. Sm sera react with both snRNP particle 
classes due to the ability of these antibodies to recognize each protein 
component (A-G). Recognition of the A protein is sensitive to RNase 
treatment for both sm and RNP sera. T\fo patients have been observed to 
undergo a change in serum antibcx^y from Sm towards RNP-like recognition 
over the course of time. 
Use of the antibcx3y reagents has been of considerable utility in 
determining aspects of snRNP biochemistry and assembly. Each snRNP protein 
was observed to be the prcxiuct of translation from a unic^e mRNA species. 
Pulse-chase analysis revealed assembly of Ul (10S) snRNPs to be a 2 step 
process involving prior formation of a 5S core particle, followed by the 
addition of A and C proteins, 'fliese experiments also revealed the presence 
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of one and possibly a second post-translational modification of snRNP 
proteins C and D (respectivelyi . The mcx3ification of C protein follows 
(kinetically) assembly of this species onto the los particle. The second 
mc5dification is observed by the action of a serum component on the C 
protein and remains undefined at present. 
A series of apparent coincidences among these results may bear 
mention. Specifically, the unique metabolism as well as immunologic 
recognitin of A and C proteins is perhaps of broader significance. Ttiese 
proteins are uniquely added in the second step of Ui snRNP assembly, but 
are also uniquely (and exclusively) recognized by anti-RNP antibcx^ies as 
well as antibcx3ies in certain Sm patients who have switched to a RNP-like 
pattern of recognition. Furthermore one of these two peptides ( D protein) 
is the only snRNP protein recoverable from cells in a detectable 
unassembled form. The other species (A protein) uniquely requires Ul RNA 
for antigenicity. As such unassembled A protein is not likely to have been 
detected even if present. Perhaps metabolic aspects of the handling of 
these peptides are related to either their presentation or immunologic 
recognition in autoimmune disease. 
* * * 
The following is a proposal which relates immunologic recognition to 
the problem of autoimmunity. Vfliile not dealing specifically with any 
antigen systems in disease, these ideas may be of some interest on a wider 
scale. 




1) the vastly disproportionate occurance of SLE in females over 
males (~9:1), as well as frequent observations of x-chromosome 
abnormalities in afflicted males (e.g. Klinefelter*s Syndrome, Stern, et 
al. 1977). 
2) several reports of increased HLA-locus compatibility (or 
identity) between husbands and wives in association with high incidences of 
spontaneous abortion; that is, sharing of these transplantation antigens is 
associated with maternal difficulty in successfully bringing a pregnancy to 
term (Faulk and Mclntyre 1981; Komlos, et al., 1977. Beer, et al., 1981; 
Gerencer, et al., 1979). 
While a relationship between these two observations is not overtly 
apparent, an attempt to draw one will be made here, beginning with the 
second observation. The maternal-fetal immunologic relationship has long 
been problematic for immunologists because a fetal "graft," in cx>ntrast to 
other allografts (e.g. skin, kidney) clearly survives despite 
histoincompatibility. Ttie fact that identical rejection phencDmena are not 
occurring during normal pregnancry is clear, since the vast majority of 
husband-wife combinations (couples) and maternal-fetal combinatins are HLA 
non-identical. Ttie above observation (#2) would suggest, in fact, that 
this incompatibility is advantageous vis a vis the maternal-fetal 
relationship. While seemingly anomalous, analysis of the components of 
this recognition may perhaps reveal how such a mechanism could have 
evolved. 
Major histocompatibility gene cĉ mplexes (H-2 in the mouse, HLA in man) 
were historically appreciated because of properties of allo-recognition. 
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Ttiat is, graft rejection phenomena appeared to involve strong 
recognition/responses to polymorphisms in proteins encx)ded at these loci. 
The striking observation (in the absence of grafts) that polymorphisms of 
certain regions within these loci correlate with the ability to mount an 
immune response to a given haptene, gave rise to the notion that "immune 
r^nse" genes reside as well within these H-2 and HLA loci. Certain 
allotypes of these immune reponse gene products (now known as class TT 
histocompatibility antigens or la in mouse and Dr in man) were shown to 
endow an animal with the ability to respond immunologically to certain 
antigens. But "holes" in immune response potential to certain other 
defined antigens could be observed if theanimal lacked another (different) 
la allotype- one which was associated with ability to respond to certain 
other antigens. These experiments suggested that diversity of immune 
reponse was in some way related to diversity of la genes- or Dr in man. 
Studies of antigen recognition by T lymphocytes revealed the ability (in 
fact, the necessity) of T cells to simultaneously recognize H-7 (or HLA) in 
association with antigen on antigen presenting cells (see chapter 8). it 
would seem reasonable then, to imagine that this la or Dr restrictin in 
immune response may be effected biologically at the level of T cell 
recognition of antigen (+ H-2/t)r). Furthermore, heterozygosity of the two 
alleles for these immune response genes would be expected to provide a 
selective advantage relative to homozygosity, because increased diversity 
of immune recognition correlates with wider spectrum of antigen 
recognition. 
If maternal-fetal recognition were to exist such that diversity of H-2 
and HLA loci were selected for, one would predict that a population capable 
of such "diversity-selection" could have a selective advantage over a 
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population lacking such recognition, in this regard then, the observation 
that spontaneous, recurrent abortions are frequently correlated with HLA 
identity between husband and wife may simply reveal the presence (and 
effects) of such a "diversity-selection" mechanism. 
Further support for the possibility that such recognition may operate 
in the maternal-fetal relationship comes from reports (though mostly 
anecdotal) of difficulties encountered during animal inbreeding. Ttiese 
difficulties appear to involve low reproductive efficiency of animals when 
bred for genetic identity. A further implication of this hypothesis, if 
cx)rrect, would be that females in established inbred strains of animals may 
have lost or mutated the gene(s) responsible for this "diversity-selection" 
in the process of inbreeding. Ttierefore inbred strains of animals 
(generated frequently to test allorecognition) may contain a 
(paradoxically, selected for) defect in some aspect of their 
allorecognition. 
This cx>ncept of alio vs. self recognition in the maternal fetal 
relationship carries with it a prop)erty uniquely critical to females. 
Maternal recognition of a genetically identical fetus (appearing as 
"self") , then, may result in an immunologically mediated reaction to self 
(or "nonreaction to self") resulting in spontaneous abortion because of 
failure to support such a fetus or due to specific mechanisms which destroy 
it. Such properties might well be X-chromosome enc:oded. What has been 
described, then, amounts essentially to a female specific recognition of 
"self" with subsequent destruction of "self." Such a description bears 
remarkable similarity to the scenario encrountered in autoimmune disease-
particularly diseases such as SLE which are characterized by female 
preponderance. Considerable additional evidence has implicated X-
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chromosomal genes in immunologically critical activities, as seen, for 
example, in x-linked immunodeficiencry disease of man. In summary, then, 
this hypothesis would syggest that an immunologically mediated mechanism of 
"self" recognition normally present in females may have gone awry in 
certain autoimmune disease. 
While little has been done to test this idea, one recent report (Schur 
and Carpenter, 1983) contributes very useful data (without having addressed 
this particular issue). In this study of HLA haplotype (A and B loci only) 
correlations in SLE, the only significant observation related to the HLA 
types of parents of SLE patients. Of 70 normal parental pairs (controls^ , 
only ~4% shared HLA A, B haplotypes. Of 35 SLE parental pairs {"^^ pairs of 
SLE patient parents) , 7 shared A,B haplotype. Ttius 20% sharing was 
observed in SLE parents as compared to 4% for normals. Given the known 
genetic influence in acquisition of lupus, this shared haplotype phenomenon 
may reflect abberant fetal recognition (at some level) by the luous 
mothers. Ttiat is normal couples with shared haplotypes may have had less 
success in producing viable offspring. A second observation which may in 
some manner relate to the above hypothesis involves the observations (Mund, 
et al., 1953) of pregnancy's profound influence over the course of disease 
activity in lupus patients. 
Further analysis of genetic loci possibly Involved in such a 
recognition process may in the future be amenable to study by use of 
restriction fragment length polymorphisms (RFLP) technology (Botstein, et 
al., 1980). 
If "diversity-selection" is, in fact a real biological phenomenon, its 
biochemical basis would be expected to reside at the level of T lymphocyte 
recognition of antigen. Delineation of structures possibly involved in 
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Elucidation of structural properties of the T lypmphocyte receptor for 
antigen has represented one of the most profoundly elusive problems in 
modern immunology. The characterization of numerous functional properties 
for T cell subpopulations has helped establish the exquisite antigen 
specificity of these cells. Ttie dual nature of T cell antigen recognition 
by T lymphocytes was established by the discoveries that antigen 
recognition occurs specifically in the context of prcx3ucts of the major 
histocompatibility complex (MHC) (Benacerraf and McDevitt 1972; Zinkernagel 
and Doherty 1975; Schlossman i<^72). This dual specificity of T cells for 
both antigen and MHC gave rise to two theories which may account for T cell 
receptor recognition (Zinkernagel 1978). A first model proposes the 
existence of two distinct receptors: one specific for antigen and another 
specific for MHC. Presumably appropriate binding to both receptors would 
serve as antigen recognition. A second model involves the notion of a 
single receptor which recognizes a single "antigen" which itself contains 
determinants derived from both MHC and real antigen. 
Ttie determination of antigen reactivity by T cells has been studied in 
vitro by incubation of the T cells with antigen and appropriate accessory 
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cells. Stimulation by antigen has been measured by H-thymidine 
incorporation, 11-2 secretion, as well as biological function. Ttie 
critical role of accessory cells in helping to generate the T cell 
antigenic response has been extablished for some time (Hersch and Harris 
1958; Cline and Sweet 1958). Numerous studies have argued conclusively for 
the role of adherent mononuclear cells in this activity (Seeger and 
Oppenheim 1970; Rosenwasser and Rosenthal 107R), qtie prevailing notion 
that the monocyte/macrophage population is primarily responsible for such T 
cell activation phenomena has recently come into serious question with the 
reports of highly potent stimulating capacity for dendritic cells fSteinman 
and Nussenzweig 1980) of mouse (Steinman, et al., 1983; Sunshine, et al., 
198"^) and man (Crow and Kunkel 1982; Van Voorhis, et al.,1083). Ttie 
relatively weak stimulating capacity of purified monocytes (Steinman and 
Nussenzweig 1980) has argued more conclusively for the primary role of 
dendritic cells in this T cell stimulation. 
Use of an in vitro T cell antigen specific system has recently been 
made to provide strong evidence for the "one receptor" theory of antigen 
recognition, in these experiments (Kappler, et al., 1981) hybridomas were 
derived from two T cells each with specificity for a certain antigen and a 
corresponding MHC type. Resulting hybrids were unable to respond to one 
antigen plus the other MHC type, but could only respond to the same 
combinations of antigen plus MHC as the cells used for fusion. Ttiis result 
argued strongly for the liklihood of a single T cell receptor for antigen 
plus MHC. 
Considerable attention has been paid to the possibility that the T 
cell receptor structure may utilize gene prcx3ucts in common with 
immunoglobulin. Specifically, the use of anti-immunoglobulin antibodies 
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appeared to recognize T cell structures which may relate to antigen 
recognition (Binz, et al., 197*=^). This and numerous other reports 
suggesting immunoglobulin characteristics of the T cell receptor were not, 
however, general izeable and as such did not lead conclusively to 
determination of a receptor structure. More recently several laboratories 
provided evidence for the possibility that idiotypic structures contained 
in the T cell receptor may be derived from the same gene segments (v„) as 
n 
in the case of antibody heavy chain (Binz and Wigzell 1977; Rajewsky and 
Eichmann 1977; Krarrener 1981). Other groups (Hammerling, et al., 1Q''5; 
Bach, et al., 1979; Mozes and Haimovich 1979; Suzan, et al., 1^81; Owen, et 
al., 1931) described genetic linkage of T cell antigen recognition 
structures to the immunoglobulin heavy chain locus. CVen, et al. (1^79^ 
1981) furthennore mapped the putative recognition structures to the mouse 
chromosome 17 between the Igh-1 locus (encx>ding cx)nstant region genes of 
immunoglobulin heavy chains) and the prealbumin gene. Similar 
alloantigenic molecules were observed as secreted T cell products 
(Taniguchi, et al., 1982; Tokuhisa and Taniguchi 1982). A number of 
studies, however, have demonstrated lack of shared gene prcx^ucts for 
immunoglobulin and the T cell receptor for antigen. Immunoglobulin joining 
and constant region gene transcripts could not be detected in T helper or 
killer cells (Kronenberg, et al., 1980). Furthermore, the use of gene 
probes derived from v„ gene segments and presumed to be capable of very 
H 
wide recognition of v„ genes failed to detect homolagous transcripts in T 
n 
cells (Kronenberg, et al., 1983) even when V„ probes were derived from B 
H 
cells with the same antigen specificity as the T cells (Kraig, et al., 
1983). Thus, although the possibility remains that shared determinants may 
exist for immunoglobulin and the T cell receptor, sharing of actual gene 
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segments appears to be unlikely. 
Considerable advances have recently been made in the understanding of 
T lympjhocyte populations by application of the monoclonal antibody 
technique (Kohler and Milstein 1075) to the study of T cell surface 
proteins. Among the more important such markers in humans are the 
molecules recognized by the antibodies OKT'', T4, and T8 (Reinherz, et al., 
1983). T4+ T cells appear to recognize class II MHC determinants while TP+ 
cells recognize class I MHC structures (and the cells bearing these markers 
are mostly help)er and c:ytotoxic cells, respectively) . Ttie T'' molecule 
appears to reside on all mature T cells and has been implicated as 
important in antigen recognition by virtue of the ability of antibody 
against this structure to block antigen specific T cell activation. The 
considerable specificity of monoclonal antibodies directed against T 
lymphocytes may be of further use in delineating important structures in 
antigen recognition. It is the use of this methodology which forms the 
basis of the analyses of the T cell receptor which follow. 
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Chapter 8 
T Cell Receptor Structures on TVo T Cell Leukemias 
ABSTRACT 
Monoclonal antibodies were obtained that displayed unique recognition 
of a surface protein epitope on each of two T cell leukemias. Ttiese 
reactivities resemble anti-idiotypic antibodies in the specificity of their 
recognition. For each T cell leukemia, a second monoclonal antibody was 
obtained which recognized the same molecule as the idiotype-specific 
antibodies. Ttiis second set of monoclonals, however, was capable of 
staining a certain fraction of normal T cells, suggesting the recognition 
of a cross-reactive or constant region determinant. Ttie molecules 
identified in these studies are both disulfide-linked heterodimers. One is 
70-75 kd unreduced, and contains a crossreactive determinant with ~2% of 
normal T cells. Ttie other is 80-00 kd unreduced and contains a determinant 
present on 30-5^% of normal T cells. By virtue of immunochemical 
properties of these surface proteins, as well as biological effects of the 
antibodies directed against them, these molecules would appear to be strong 
candidates for the T lymphocyte antigen receptor. 

REAGENTS 
Ttie strategy for identification of the T lymphocryte receptor for 
antigen relies on analcxgy between this putative structure and the B cell 
antigen recpetor: immunoglobulin. A clone of B cells would likely share 
antibody idiotypic determinants with no other cells. Antibodies directed 
against constant region domains of immunoglobulin would, however, be likely 
to recognize other B lymphocytes as well. 
Ttie antibody reagents used in these studies were mouse monoclonal 
antibodies generated by Dr. Robert Bigler and Dr. David Posnett by 
immunization of mice with leukemic cells from twD T cell leukemia patients. 
patient Su 
T lymphocytes from this patient were of the Sezary type. Leukemic 
cells displayed the phenotype: E rosette +, 0KT3+, 0KT^->-, 0KT«-, la-, 
sig-. Following immunization and fusion, two hybridc5mas of interest were 
obtained. Surface staining, as measured by indirect immunofluorescence, 
revealed one of these antibodies (called SI50) to stain exclusively the 
immunizing T leukemia cells. Cells failing to show any staining included: 
autolagous and allogeneic normal B and T cells, other T leukemias, myeloid 
cells, B and T cell lines, activated normal B and T cells. Thus the SI50 
antibody appears to be entirely specific for this leukemia cell. 
A second monoclonal antibcxJy (called SVll) displayed nearly identical 
staining patterns, with the important distinction that approximately 2% of 
normal resting T lymphocytes stained strongly with this antibody. Ttie SVll 
antibcxJy therefore recognizes a determinant shared by the leukemic clone of 





The immunizing leukemic cells were derived from a T cell chronic 
lymphocytic leukemia. F»henotypically the cells were E rosette +, OKT''+, 
0KT4+, 0KT8-, la-, Tacf, sig-. From the resulting hybridomas, one (termed 
FF25) exhibited exclusive staining of the immunizing cells. All other cell 
populations examined including autolagous and allogeneic leukocrytes did not 
stain with FF25. Ttiis antibody, therefore, apjpeared to display complete 
specificity for the leukemic cell clone. A second monoclonal, termed FFB"^, 
reacted both with the leukemic cells and 30-50% of normal T cells, as well 
as with several T cell lines. A second recently obtained antibcx3y (FFB3) 
appears to recognize 30-50% of stimulated normal T cells as well as the 
immunizing leukemic cells and is discussed below. 
RESULTS 
Analysis of the structures against which these various hybridomas were 
directed was carried out by solubilization of the appropriate surface 
iodinated leukemic cells followed by immunoprecipitation. These results 
are shown for the SI50 and SVll antihnDdies is Figure 21. Using Su cells, 
lanes 1 and 5 show unreduced forms of SI50 and SVll immunoprecipitates, 
respectively. A 70,000 d heavily labeled protein app^s for both 
antibodies, upon reduction with dithiothreitol (lanes "^ and 7), the 70,ooo 
d protein is not seen, but two smaller peptides appear for both antibodies. 
Ttie smaller component is about 38,000 d and much more heavily labeled than 
the slightly larger 43,000 d species. Analysis of immunoprecipitates using 
these same antibodies, but with different cell extracts (T cell line KE37) 
are shown in odd numbered lanes in Figure 21. In parallel to the staining 
patterns for these hybridomas, no antigenic peptides are visibly 
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immunoprecipitated from this T cell source. 
Further analysis of the disulfide reduction property of the protein 
recognized by these two monoclonals was carried out by cutting out the 
70,000 d (unreduced) band from a first gel, rehydrating in buffer 
containing dithiothreitol, and electroeluting into a second SDS-
polyacrylamide gel. Figure 22 shows the 70,000 d and two lower bands in 
lanes 1-3, rehydrated in the absence of reducing agent. However in the 
presence of reducing agent (lanes 4-5) the 70,000 d band is directly 
converted into the two lower molecular weight bands. It is of some 
relevance that the 3*^,000 d band has uniformly appeared much more heavily 
labeled than the 43,000 d species. Ttiese differences may arise due to 
differing numbers of icx3inated tyrosine residues, or incxjmplete icx5ination 
due to membrane properties of the cell. Analysis by 7-dimensional gel 
electrophoresis (performed by Dr. C. Y. Wangi has revealed 
microheterogeneity for both of these peptides, consistent with 
glycosylation patterns. 
Numerous attempts have been made to use these two monoclonal 
antibodies as aids in obtaining cDNA clones for the molecule under study. 
RNA extractions were carried out both by NP-40 lysis and phenol extractions 
(to obtain c:ytoplasmic RNA) and guanidinium thiocyanate (yielding total 
cellular RNA). One difficulty in working with these leukemic cells is 
their extraordinarily small size and their low yield of RNA upon 
extraction. Ttie similar RNA yields obtained using guanidinium salt 
extractions argues against degradation as the cause of low RNA yields. 
Furthermore, oligo dT cellulose chromatography led to the isolation of 
under 2 ug of poly A+ RNA from 4 mg of total RNA of the Su cells. 
Ttierefore, a very powerful cDNA cloning system was needed given such a 
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small cyjantity of starting material. Using the lambda gtio vector a cDNA 
library was constructed from Su poly A+ RNA which contained approximately 
200,000 members. 
parallel experiments were performed to determine a manner which one of 
the monoclonal antibodies might be useful in identifying clones of 
interest. Attempts at immunoblots (Western blots) failed to display 
antibcx3y recognition- likely suggesting considerable detergent sensitivity 
of the antigenic determinants. Immunoprecipitation of Su cell extracts 
which were previously reduced and alkylated (using iodoacetamidel also 
failed to reveal antigen recognition by these monoclonals. A realistic 
conclusion from these studies suggests the likihocx3 that determinants 
recognized by both monoclonal antibodies in some way require intact linkage 
of the two chains together, for successful antibody recognition. Such 
recognition behavior would be similarly sensitive to reduction and 
denaturation in the case of antibodies directed against idiotypic 
determinants on immunoglobulin. Inability to immunoprecipitate Su RNA in 
vitro translation products using these antibodies further supports this 
notion (data not shown). 
It therefore became evident that more broadly reactive antibcx3ies to 
the same molecule would be of greater aid for further molecular biological 
study. 
To that erid, a strategy was devised to prepare a rabbit antiserum 
directed against the same molecule. Unlabeled Su leukemic cell lysate was 
immunoprecipitated onto protein A sepharose beads which were washed and 
immunized directly in Complete Freund's Adjuvant into two rabbits 
intraperitoneally. Following 2 months of weekly immunizations, sera were 
tested for reactivity by immunoprecipitation but failed to reveal any 
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reactive antibodies. Immunizations were then continued using immune 
complexes (as above) this time adsorbed onto formalin fixed staph aureus 
organisms. Following 3 months of further immunization, sera were obtained 
125 
and used to immunoprecipitate ' T-labeled Su cell extracts, as shown in 
Figure 2"^. Patterns are seen both for the SVll monoclonal antibody 
(positive control) as well as for the rabbit immunoprecipitates, reduce^d 
and unreduced. Clear evidence exists for appearance of the identical 
protein precipitates, recognized by the rabbit antibodies. 
A second monoclonal T cell system was amenable to similar analysis, 
with the development of monoclonal antibody FF75, reactive with malignant T 
125 
lymphocytes from patient Fi. Immunoprecipitation of I-labeled Fi 
extracts with FF25 antibody was carried out alongside immunoprecipitates of 
Su cells using SVll antibody. As seen in Figure 24 lanes 1 and '', the FF7^ 
antibody also recognizes a disulfide linked heterodimer. However, several 
clear properties distinguish this molecule from the pattern obtained by 
SVll antibody and Su extract (lanes 2 and 4). The unreduced protein from 
Fi migrates at about 00,000 d, compared to "•70,000 d for Su. Ttie two 
reduced peptides migrate at approximately 52 and 4 3,000 d as compared to ^3 
and 38,000 d for Su. Both molecules apjpear to contain a heavily labeled 
and a lightly labeled ccmponent (see reduced forms, lanes 3 and 4). Ttie 
lightly labeled peptides appear to comigrate indistinguishably for the two 
cell sources, v^iile the heavily labeled peptides differ considerably in 
migration. A second monoclonal antibody, FFB3, has recently been obtained 
which shcjws reactivity with not only the immunizing T leukemia cells, but 
also 30-50% of normal T cells and several T cell lines. Secguential 
immunoprecipitation has indicated (data not shown) that FFB3 recognizes the 
same molecule as the idiotype-specific antibody, FF25. 
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Towards eventual isolation of cDNA clones for the proteins studied in 
Fi cells RNA was extracted and a cDNA library consisting of approximately 
100,001^ members was constructed in lambda gtio. 
Tise of T cell-specific cT>JA probe 
The use of monoclonal antibodies as probes for T cell specific 
membrane markers has a theoretical parallel utilizing techniques of 
recombinant DNA. Specifically, the generation of a T-cell "specific" probe 
would be expected to identify cDNA clones unique to T cells and, perhaps, 
including the gene(s) encoding the receptor for antigen. 
Attempts at such a strategy have been made utilizing the human T' cell 
line HTfr-"'02 from which a 250,000 member cDNA library was generated. Ttie 
strategy for gene identification involved first generating a T cell 
specific CDNA probe (by hybrid depletion) and screening of the Wjv library 
for T cell-specific genes. Putative candidates would be screened by 
Southern blot analysis for the presence of a gene rearrangement by analogy 
with observations in the immunoglobulin genes of B cells. 
Generation of T cell-specific probe employed the use of T cell poly A+ 
RNA and B cell line (IM-9, kindly provided by Dr. Nicholas Chiorazzi) poly 
32 
A+ RNA. HUT P-cDNA was hybridized to IM-Q poly A4- RNA m vast excess. 
Single stranded and double stranded nucleic acids were then separated by 
use of hydroxyl apatite chromatography. In the presence of 0.1 M phosphate 
buffer, only double stranded nucleic acids bind to the colimn. Single 
stranded nucleic acids (and presumably T cell-specific cDNAs) are thus 
separable in this step, from double stranded forms, v^ich can be eluted 
with 0.4 M phosphate. Ttie relative proportions found in single and 
double-stranded forms are quantitated by counting the various fractions. 
An index of completion for such nucleic acid hybridization reactions is the 
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R t value, a number reflecting the influences of both concentration and 
o 
time on degree of hybridization. In brief, the relationship of R t to 
completion of the hybridization reaction is given in the following 
derivation. 
37 
For the hybridization reaction: ( * connotes P-labeled) 
TmRNAl + FcDNA*! K v RNA:cDNA* 
If R=fmRNAl and C=fcrNA*l and R»C (reaction is run in vast excess) , then 
the rate of this reaction is given by pseudofirst order kinetics and rate 
of disappearance of cDNA with time is: 
-(dC/dt)=KRC. 
K represents a pseudofirst order rate constant which depends on complexity 
and may (in theory) vary among different cell types. Rearranging the above 
equation gives: 
-(dC/C)=KRTdT 
which may be integrated between times t to t and for cDNA concentrations 




Rearrangement of this expression gives: 
C /C ^e-"^^ 
Since R»C, R^ is approximately equal to R . Therefore the equation 
describing the rate of disappearance of single stranded cDMA probe shows 
the hybridization to be a function of the two variables R (or B cell A+ 
o 
RNA concentration) and t (time of hybridization) . In the case of HeLa cell 
poly A+RNA (hybridizing to its own cDNA), hybridization to a R^t of 10^ 
((mol.s)/l) gave approximately 90% SI nuclease resistant (i.e. double-
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stranded) cDNA-RNA hybrids (Bishop, et al. 1974). Hybridization of HUT 
CDNA with IM-9 A+ RNA was therefore carried out to a R Qt 
of approximately 28no (with the purpose of driving the reaction as far as 
possible) . However, Northern blot analysis of this select probe revealed 
very extensive hybridization to B cell RNA. Further B-T hybridizations 
were therefore carried out to determine conditions under v^ich a cleaner 
(more T cell specific) cDNA probe cx)uld be generated. Figure 75 shows the 
proportions of single and double stranded cDNAs following sequential 
hybridizations to B cell RNA. Ttiese results indicated that two rounds of 
hybridization (R t=500) left cDNA, only 2% of which was capable of forming 
hydroxy apetite separable duplexes following a third round of 
hybridization. Ttierefore, more cDNA specific probe was generated by 7 
rounds of hybridization to IM-o RNA. Northern blot analysis of this probe 
appears in Figure 25 and shows considerable enrichment of T cell 
reccxgnition over B cell. Reactivity with certain specific B cell RNA 
species remained, and is presumed to represent a population of probe 
species not amenable to removal by this method. 
Such twice-hybridized T cell-select cDNA probe was then used to screen 
15,000 clones from the HUT 102 lambda gtll cDNA library. 7/J5 plaques 
showed strong binding to this probe representing 1.5% of the clones. An 
example of one filter showing about 20 positive clones is seen in Figure 
27. Ttiis same filter was a replica of a plate containing approximately 500 
total plaques (thus '"4% of plaques were positive on this plate) . Further 
analysis of these putative T cell specific clones required that they first 
be plaque-purified (that is, purified by 2° screening away from 
neighboring, contaminating phage). Having purified approximately ^0 of 
these candidates, the first 5 were amplified and tested on Northern blots 
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for their T cell specificity. Ttiese particular Northern blots (Figure 7P) 
contained total RNA from both B (IM-9) and T (HUT 102) cell sources. Ttie 
unexpected result seen in 3 out of "^ clones tested revealed a heterogeneous 
smear of hybridization particularly strong in the T cell lane and 
identification of a small RNA species in both B and T cell RNAs (probes 3, 
4, and 5). Intactness of the RNAs in these blots was verified by 
rehybridization of one of the same blots (after washingi with a separate 
probe (Figure 29) for a unique sequence gene (provided by Dr. Hung Teh 
Kao), The suspicion that these unusual hybridization patterns may reflect 
the presence of repetetive sequences in the probe was tested by 
hybridization to one of the same blots (after washing and reexposure to 
St 32 
ascertain removal of the i probe) of "P-labeled nick translated human 
gencmic DNA (derived frcxn the Raji cell line) . The result, seen in Figure 
30, reveals the identical pattern of hybridization, highly suggestive of a 
pattern for repeat sequences within the probe. Ttie small RNA band likely 
represents the small RNA 7s which has been shown to contain Alu-type 
repetetive sequences (Reddy and Busch 1983). 
The presence of repetetive sequences among such putative T cell 
specific clones may be the result of a high level of expression in HITT* IO7 
of mRNAs containing repeat sequences. As such, the increased expression of 
such rep)eat-containing genes (relative to IM-9 c^lls) may perhaps be of 
relevance to functional properties of this class of sequences. 
Alternatively this expression pattern may represent a relic of 
transpositional activity at some stage in the derivation of the HUT 102 
cell line and be of little functional significance at present. Methods 
could be devised (in principle) to overcome this problem. For example, 
random sequence primers for the P-cTNA probe sunthesis could be used in 

-07-
conjunction with boiling to break the probe into small pieces. Such a 
mixture should contain representations of all the mRNA sequences, but on 
nimerous small pieces. A hybridization reaction with genomic DMA should 
remove all fragments containing repetetive sequences, while leaving unique 
sequence-specific fragments. Such a procedure, however, while 
theoretically feasible, would require synthesis of an enormous quantity of 
32 
P-labeled cDNA starting material- an exceedingly difficult task using 
random cDNA primers. For these reasons, a better approach would likely 
involve selection of a different T cell source of RNA- particularly if one 
can be found which lacks the high level of repeat sequence expression as in 
HUT-102. 
DISCUSS THNT 
Several monoclonal antibcx3ies have been described which appear likely to 
recognize structures with characteristics in common with a pjutative T cell 
antigen receptor. Although no direct evidence has been obtained for the 
notion that the identified structure is an antigen receptor, considerable 
indirect evidence supports this notion. Antibodies directed against 
similar disulfide linked heterodimers have been shown to block specific 
activities in both mouse and cytotoxic human T cell antigen specific 
systems (Meuer, et al., 1983; Haskins, et al., 1083). A co-modulation 
phenomenon has also been described (Reinherz, et al., 1982) in which the T 
cell receptor complex is postulated to contain several elements, one of 
which is the peptide recognized by the OKT'' monoclonal antibody. Tn 
modulation experiments, a given monoclonal antibody is bound to target 
cells, which are then incubated for 12 hours at 37°c. Upon restaining at 
that time, the percent positive cells may decrease for a second antibody. 
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if its target surface antigen has "cx>-modulated" off the cell surface 
together with the target for the first antibody. Co-modulation is in some 
sense considered an index of associations between different proteins in a 
cell membrane. By these analyses, the SI50 and SVll antibodies as well as 
FF2^ have all been observed to co-modulate with the OKT"? molecule (data not 
shown) , further supporting the possibility that these monoclonal antibodies 
recognize molecules important in T cell antigen recognition. 
Perhaps the most compelling evidence that the targets for these 
monoclonals are T cell receptor molecules, is the idiotype-like cfualities 
demonstrated by the antibodies. Ttie unique reccxjnition of only a single 
clone of T cells (as seen with SI'^O and FF25) is highly reminiscent of 
patterns obtained by similar analysis of anti-idiotypic reagents on 
monoclonal B cell sources. If antigen recognition requires diversity-
enccx3ing elements which differ depending on antigen specificity, then the 
presence of idiotypic determinants would be a prerequisite for the 
expression of such diversity. 
Several other groups have described similar monoclonal antibody 
systems reactive with T cells in idiotype-like fashion, both in mouse 
(Allison, et al., 1982; Haskins, et al., 1083) and humans (Meuer, et al., 
1983) Vfliile the recognized molecules have been identified as disulfide 
linked hetercx^imers, the sizes of previously reported molecules have all 
been similar to the antigen rec!ognized by FF25. The Su molecule appears 
somewhat smaller than the others, and may correspondingly represent a 
different i so type for the T cell receptor than has been recognized in the 
other systems. Particularly striking evidence that the SVll and FFB"» 
recognized molecules are antigen receptors relates to the fact that the 
molecules appear to contain both unique and shared determinants- analagous 
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to variable and constant domains of immunoglobulin. 
The shared SVll determinant demonstrated by binding to normal T cells 
of S\^ll antibody, is relatively rare among T cells (""2%1. It should be 
noted however, that antibodies directed against constant determinants of 
(for example) IgA or IgE would similarly recognize only small populations 
of circulating B lymphocytes. Ttie SVll antibody, then, may recognize a 
relatively rare isotype (or "class") of T cell receptor molecule. An 
alternative type of recognition which may be operating for the S\m 
monoclonal is cross-reactive idiotypy, wherein a shared determinant is 
recognized from among variable regions of (isotypically) different 
molecules. If this were the case, then an antiserum such as that obtained 
by the rabbit immunizations (see Figure 23) should provide a vehicle for 
the examination of constant region determinants. Antibodies present in 
this same serum may as well be of further help in recognition of primary 
translation products for the various chains, and as such may assist in 
identifying cDNA clones encoding the proteins of interest. Analysis of 
structural differences among the molecules on normal T cells reactive with 
SVll antibody will be carried out when monoclonal cell lines derived from 
that population can be expanded appropriately. At that stage, peptide 
mapping and further serologic studies may reveal more information regarding 
variable and constant dcxnains of the T cell receptor. 
Ttie cross reactive determinant recognized by the FFB3 monoclonal 
antibody is present on a large population of normal T cells ('^0-50%). If 
this recognition involves a distinct isotype, it would be a relatively 
common isotype of T cells (analagous to Tgvi or IgG isotypes among B cells). 
An intriguing recent result is the observation that an 80 kd protein which 
comigrated with this Fi idiotypic molecule was identified by western 
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blotting using a monoclonal anti-HLA antibody. As with the SI50 and svil 
antibodies, FF2^ and FFB3 display no recognition on Western blots-
presumably due to SDS-denaturation. Ttiis HLA monoclonal antibody, however, 
reproducibly identifies the 45 kd HLA heavy chain by Western blotting (or 
immunoprecipitation). When this antibody is used to probe a Western blot 
containing Fi leukemia cell lysate run unreduced, an 80 kd peptide is 
visualized (as well as the 45 kd HLA). Ttie higher band disappears upon 
reduction- as predicted for the idiotypic molecule. One possible 
explanation for these results is that perhaps the smaller peptide in the Fi 
idiotype molecule ^is HLA heavy chain. This appears to be unlikely, 
however, because immunoprecipitation with numerous anti-HLA antibodies 
including polyclonal rabbit antibcxdies never resulted in identification of 
the Fi molecule. A second, more likely, alternative is the possibility 
that this idiotype molecule contains a determinant in common with HLA, but 
one which is not normally exposed in the molecule. SDS denaturation may 
expose the determinant on Western blots. Such homology to HLA would not be 
unprecedented cmong surface molecules in the immune system (Williams 1OP4), 
Further analysis of these possibilities is underway by use of peptide 
mapping. 
Of particular value is the observation that the FFB"^ antibody binds to 
several immortal T cell lines (.lurkat and Cem-T, data not shown) . As such, 
isolation of large cpantities of RNA should be easier than was the case for 
the 2 leukemia cell sources. Comparison of molecular features at the 
protein level will be of equal interest, using these reagents. 
Finally, several recent reports (Yanagi, et al., 1084; Hedrick, et 
al., 1984a,b) have described the identification of T cell cDNA clones 
derived by plus/minus screening or hybrid depletion similar to the 
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techniques employed in the HlfT 102 experiments described here. Ttiese gene 
products appear to contain both constant and variable nucleotide sequences. 
The molecules encode peptides of approximately ^0-'*5,nnod. Considering 
additional glycosylation, as well as strikingly similar characteristics of 
specificity, and variable and constant sequences or epitopes, the 
intriguing possibility exists that these isolated clones may correspond to 
one of the two chains described in these studies using anti-idiotypic 
monoclonal antibodies. 
Figure 21 
Peptide recognition of 5150 and SVll monoclonal antibodies. I labeled 
Su leukemia cell extract was immunoprecipitated and resolved on a 15% SDR-
polyacrylamide gel. Lane 1) before reduction and lane 3) after reduction 
for antibody SI50; lanes 5 and 7, before and after reduction for antibody 
SVll. Lanes 2, 4, and 5 represent control precipitations with these 








Direct conversion of the 7n,oood T cell specific peptide to two smaller 
chains by disulfide reduction. Ttie upper band, as well as the twD reduced 
bands (as seen in Figure 21) were excised and rehydrated in the absence 
(lanes 1-3) or presence (lanes 4-5) of 0.1 M DTT. Lane s demonstrates the 






Generation of polyclonal rabbit antiserum to the idiotypic molecule of Su 
leukemia cells. Immunoprecipitated SVll antigen, adsorbed to formalin 
fixed staph, aureus, was injected intraperitoneally into a rabbit for 3 
125 
months. Immunoprecipitation with the resulting rabbit serum of " i-
labeled Su cell lysate is shown under reduced (red.) and unreduced (unred) 
conditions. Identity of the SVll antigen is seen under the same 










Comparison of immunoprecipitated idiotypic molecules from two different 
human T cell leukemias. Tcxdinated extracts of Si cells were 
immunoprecipitated with 5150 antibody and run under nonreduced (lane 2) and 
reduced (lane 4) conditions. Precipitation of labeled Fi cell lysates with 
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Northern blot analysis of "specific" probe. "̂  ug of T cell and B cell poly 
A+ RNA were resolved on a formaldehyde gel, followed by blotting to 
nitrocellulose filter paper. And probing with T cell cDNA probe twice 




















Screening T cell library with T cell c!i>JA "specific" probe. Twice hybrid 
depleted T cell cDNA was used to probe nitrocellulose filters cx)ntaining 
replicas of a lambda gtIO recombinant phage library from HITT cells. From a 
total of 15,000 recombinants, 245 were positive with the selected probe. 
An example is seen here of approximately 20 "positive" placjues on a filter 







Testing intactness of Northern blot RNAs giving rise to heterogeneous 
patterns. Filter #3 from Figure 28 was washed at high temperature to 
remove original probe. Ttie same filter was then probed with a known unique 
sequence gene (generously donated by Dr. Hung Teh Kao). Ttie presence of a 






Repetetive sequences in T and B cell RNAs. To test whether the patterns 
obtained in Figure 28 might be due to repetitive DNA sequences, filter *4 
from Figure 28 was washed (reexposed to ascertain removal of the first 
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Materials and Methods 
Sera, cells, and cell growth. Sm and RNP serological determinations were 
carried out by the passive hemagglutination assay described by Tan and 
Peebles (1^75). Ttie human myeloid cell line K552 was grown in RPMi 1540 
(microbiological Associates, Walkersville, Md.) supplemented with 10% fetal 
bovine serum (FBS) (Grand Island Biological Co., Grand Island, N.Y.I, 2 mM 
glutamine, and antibiotics (ccxnplete medium). 
In vivo labeling. Extended labeling was carried out by resuspending washed 
5 
K552 cells at 10 per ml in methionine-free RPMT i<̂ 4n supplemented with "'0% 
FBS, glutamine, and antibiotics as above (met-free medium). To this, o,^ 
ug per ml of methionine was added together with 100 uCi per ml of S-
methionine (800-1000 Ci/mM, New England Nuclear, Boston, Mass.l. Following 
incubation for 15 hours, cells were washed three times in ice cold 
Dulbecco's phosphate buffered saline (PBS) and lysed. Pulse and pulse-
chase procedures were carried out on cells starved (unless otherwise noted) 
for two hours in met-free medium. Methionine-starved cells (usually ^ X 
7 
10 ) were pelleted and loo ul met-free medium supplemented with 500 uCi 
35 
• S-methionme was added. Ttie cell suspension was incubated for eight 
minutes at 37 c followed by immediate resuspension in 50 ml of ice cold 
PBS. In chase experiments, pulsed cells were resuspended in complete 
5 
medium at a density of 10 per ml. TXiring chase, cells were incubated at 
37° C and appropriate aliquots were removed, washed in ice cold PBS, and 
extracted at the time points listed in the legend to Figure lo. 
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Cell lysis and immunoprecipitation of snRNPs. Following three washes in 
ice cold PBS, cells were swelled for 10 minutes on ice in 10 mM KCl, 10 mM 
Tris-Cl (pH 7.5), 5.0 mM iodoacetamide, 0.*^ mM 
phenylmethylsulfonyl fluoride, 1.0 mM EDTA. Cells were then lysed by "'2 
strokes using a Dounce homogenizer. NaCl was added to 0,2 M and the lysate 
was clarified by centrifugation at 17,000 x g for 8 minutes. 
Immunoprecipitation of the lysate was carried out by the addition of ^-10 
ul of appropriate patient serum p)er immunoprecipitate. Cells were lysed at 
5 7 5 
10 -10 per ml, and each immunoprecipitate was derived from 1-5 X 10 
cells. After one hour at 4°c, 40 ul protein A Sepharose 4B (Pharmacia, 
piscataway, N. J.) was added and the tubes were rotated for an additional 
hour at 4°C. Immunoprecipitates were washed four times with 0,^% NaDodS04, 
2.5% Triton X-100, 50 mM Tris-Cl (pH 7,5), 0.15 M NaCl, 1.0 mM EDTA, and 
0.25 M sucrose followed by two washes with 50 mM Tris-Cl (pH 7.5), o.15 M 
NaCl, 1.0 mM EDTA, 1 % trasylol. 
RNA extraction methcx3s 
The perchlorate extraction methcx3 for isolating total cellular RNA. Ttiis 
method (Lizardi and Engelberg, 1979) has been used for RNAs prepared for in 
vitro translation experiments. Washed cells are resuspended in 2.4% SDS, 
100 mM NaCl, 7,s mM EDTA, 20 ug/ml polyvinyl sulfate, 25 mM Tris pH 7.4, 
and 350 ug/ml proteinase K. Following 15 minute incubation at 77°c, 4 ml 
of 3.5 M Na Perchlorate was added to 5 ml of cell lysate. Ttie mixture was 
heated to 50 C until it became clear. Following shearing through a 70 
guage needle, 40 ml of EPR reagent was added. EPR is made by mixing i 
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volume of saturated sodium perchlorate (in water) with 4 volumes of EtOH 
(which is also salt saturated) . Ttie EPR reagent is added slowly. Ttie 
resulting mixture is incubated at 4°c for 30 minutes, and precipitated 
nucleic acids are collected by centrifugation at 30onxg for io minutes 
(5°C). The pellet is dissolved in 15 ml 25 mM Tris pH 7.4, 0.7% SDS, 1 mM 
EDTA, and nucleic acids were reprecipitated by addition of NaCl to O.IP M 
and 0.5 volumes isopropanol and incubation at -20°c for 4 hours. 
Following an EtOH precipitation step (in the presence of 0.7 M NaCl) RNA 
was reprecipitated in 7.5 M LiCl at o°C for 10 hours. LiCl precipitation 
was followed by 3 further Eton precipitations. 
The NP-4 0 methcxJ of preparing cytoplasmic RNA. 
To a 1.5-2 ml. prewashed and cooled cell pellet, 9 ml. Isohi pH (io mM Tris 
pH 8.4, 140 irf̂  NaCl, 1.5 mM MgCl^) and i ml. 5% NP-40 is isohi pH are 
added, on ice. Following handmixing for 5 minutes, nuclei are removed by 
centrifugation and the supernatent is extracted with phenol (2:1), 
phenol/chloroform (l:i:l), and chloroform (7:1). RNA is precipitated 7 
times in 0.2 M NaCl and 2.5 volumes EtOH. 
The Guanidinium/CsCl2 Method of Prep>aring Total Cellular RNA. The 
following solutions are used: 
GTC Lysis solution: 
47.7 gm Guanidinium Ttiiocryanate 
10 mL 0.5 M EDTA 
10 mL 1 M Tris pH 7,/i 
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7 mL straight 2-mercaptoethanol 
H20 to 100 mL 
5.7 M CsCl2/ 50 mM EDTA solution: 
95 gm CsCl7 
10 mL EDTA 
H20 to 100 mL 
To 1 volume washed packed cells 10 volumes of GTC solution, are added. DNA 
is sheared by either vortexing, or passage through a gauge 7o needle. 
In an SW40 tube, a 2-3 mL 5.7 M CSC12/ 50 mM ETTA cushion is first poured. 
Ttie extract is layered on top of the CsCl2 cushion. Spin at ''5 K at 20 C 
for 24 hours. The pellet at the end of the spin consists of cellular RNA. 
Top layers are aspirated off the pellet, v^ich is inverted and drained. The 
pellet is dissolved in a convenient volume of H.O and extracted with 
phenol:chloroform and chloroform. RNA is recovered by ethanol 
precipitation (twice). 
Poly A selection 
Total RNA is loaded onto an oligo dT cellulose column, preequilibrated in 
wash buffer (0.5 M NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.5% SDS). RNA is 
reapplied 3-5 times. Column is washed with 20-3o volumes wash buffer and 
eluted with 10 mM Tris pH 7.s, l mM EDTA, 0.5% SDS, in as small a volime as 
possible. EtOH precipitation is carried out (X3). For more stringent 
washing, a 10% formamide wash step may be included. 
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Cell free translation system 
Preparation of wheat germ extract 
550 ml of CCl. and 270 ml of cyclohexane are mixed. 4o gm wheat germ are 
added (obtained from local health food store). Following brief stirring, 
remove floating embryos onto filter paper under suction. Dry thoroughly 
(minimum of one hour). A sephadex G-''5 column (2.5x1 oo cml should be 
preequilibrated in a cold room with running buffer (40 mM Hepes pH 7.^^, loo 
mM K acetate, 4 mM DTT, 5 mM Mg acetate - adjusted to pH 7.^ with KOH). 5 
gm of floated embryos are added to a liquid N cooled mortar to which 7? ml 
of homogenization buffer (40 mM Hepes pH "^.5, lOO mM v acetate, 1 mM 
!AgAcetate, 2 mM CaCl^, 4 mw DTT - adjusted to pH 7.^ with yn^) are added, ^ 
ml at a time. Ttie homogenate (paste) is scraped into a Corex tube and spun 
at 13,750 rpm using a Sorvall SS'^4 rotor, for 10 minutes, at 4 c. Remove 
the yellow lipid (top layer) , decant the extract (supernatent) , and spin it 
again as before. Ttie second supernatent is loaded onto the G-75 colimn and 
run with the fastest head possible at 4°c. Void volimn contains a white 
slurry which has the most activity. Following one last spin as above, 
aliquot and quickfreeze (N^). 
Translation 
The following conditions were optimized for K*^52 A+ RNA, extracted by 
perchlorate method. 
Wheat germ 40%, "master mix" 40%, A-»- RNA 7-5%. Master mix is composed of: 
cv 1 ox Kv 
^^EGS 50%, CB 25%, tRNA (7.5 mg/ml> 10%. '̂̂ EGS consists of TOO mM A T P 
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5%, 20 mM GTP 2%, *̂ oo mM creatine phosphate 8%, i mM io amino acids without 
35 
methionine 10%, S-methionine (10 uCi/ul) 5P%, P mg/ml creatine 
1 ox 
phophokmase 4%, 1 M DTT 4%. ^CB consists of: 1 M Hepes 77%, 7 M v Ac 
37.5%, 0.5M MgAc 2%, O.IM spermidine 7.7%, IM DTT 4%, ddH^O 77,2%. 
Immunoprecipitation of in vitro translation products was carried out by 
adjusting translation prcx^ucts to 1% Triton x-1oo, o.i M NaCl, 7c; J^M Tris-
Cl (pH 7.4), 5.0 mM EDTA, 7.c;% trasylol, 2.5 mg per ml ovalbimin, and 0,1 
ug per ml each of antipain, leupeptin, and pepstatin, and addition of 5-io 
ul Sm or RNP serum. 
Gel analysis. All washed Protein A Sepharose immunoprecipitates were 
eluted in 0.25 M sucrose, 2.0% NaDodS04, 0.1 M Tris-Cl (pH "7.4), «^.o mM 
EDTA, 0.1 M dithiothreitol, 0.005% bromphenolblue. Following 5 minutes at 
100°C, eluates were removed and applied to 15% NaDodS04-polyacrylamide gels 
(Fisher, et al., 1982) and run at 25 mA for 14 hours. Gels were stained in 
Coomassie Blue and destained, treated with ppo for fluorography (Bonner and 
Laskey 1974), and dried prior to autoradiography. 
Sucrose gradient analysis 
Pulsed and pulse/chased cell lysates were fractionated on 5-70% sucrose 
gradients in lysis buffer with the addition of NaCl to 0.2 M. Lysates frcDm 
1-2X10 K552 cells were loaded onto precooled gradients and subjected to 
simultaneous centrifugation in an SW 50.1 rotor for 7o hours at 4i,noo rpm, 
and 4°C. Gradients were fractionated with an automated fractionator (model 
185, Instrumentation Specialties Co., Lincoln, Nebraska) and fractions were 
immunoprecipitated with sm and PNP sera as above. Sedimentation standards 
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were human hemoglobin (4.2S), IgG (7S) , and catalase (US). Fractionation 
of in vitro translation products was carried out on 5-70% sucrose gradients 
in 130 mM K Ac, 3.5 mM DTT, 3 mM MgAc^, 15 mM Hepes, 80 uM spermine. These 
gradients were run at 45,ooo rpm for "'S.^ hours, using RNase A (7S>, bovine 
serim albumin (4.5S), igG (7S) , and catalase (IIS) as standards. Poly A+ 
RNA. was fractionated on iO-''0% gradients in 0.5% SDS, 10 mM NaCl, 5 mM Tris 
pH 7.4, 0.1 mM EDTA. Sixty micrograms of poly A+ RNA in the same buffer 
was heated to 85 C for 2 minutes, cooled on ice, and centrifuged in a 
Beckman Sl^MO rotor for 12 hours at 38,000 rpm, at 70^C. Following 
automated fractionation, each RNA fraction was twice ethanol precipitated 
prior to translation. 
Cell fractionation 
Pulsed or pulse/chased cells were fractionated by lysis in 10 nf^KCl, io mM 
Tris pH 1»^, 5 mM iodoacetamide, 0.*^ mM PMSF, i mM ETTA, for 10 minutes on 
ice. Nuclei were pelleted by centrifugation at 17,000 x g for 4 minutes. 
Cytosol fractions (supernate) were made o.2 M in NaCl and the nuclear 
pellet was extracted for snRNPS by resuspension in lysis buffer containing 
0.2 M NaCl for 5 minutes. Ttie nuclear extract was clarified by 
centrifugation at 12,000xg for 5 minutes. All procedures were carried out 
at 0-4°C. Nuclear and cytoplasmic extracts were immunoprecipitated using 
sm and RNP sera, as above. 
Proteolytic peptide mapping 
Radioactive protein bands were cut out from gels which had been only 
briefly stained and destained (total fixing time: less than V2 hour). 
Following rehydration in 125 mM Tris pH 5.8, 0.1% SDS, 1 mM EDTA, gel 

-174-
slices were placed into wells of a 70% SDS-polyacrylamide gel (as above 
with the addition of 1 mM EDTA to gel buffer) . Chymotrypsin (various 
concentrations in loading buffer) was overlaid into the wells, and 
electrophoresis was started. When the bromphenolblue was near the end of 
the stacking gel, the power was turned off and digestion allowed to proceed 
for V hour, followed by further electrophoresis through the resolving gel 
(Cleveland, et al., 197 7). 
Cell surface iodination, extraction, and inmunoprecipitation 
Cells were iodinated in the presence of 10 ug lactoperoxidase (Sigma) and 
7 125 
0.1 U glucose oxidase (Calbiochem) per 5x10 cells and 5 mCi Na i (New 
England Nuclear). Cells were extracted in TO mM Tris pH ^, 0.1^ M NaCl, 
0.5% NP-40, 1% trasylol for 70 minutes on ice. Wtiere immunoprecipitates 
were to be analyzed nonreduced, cells were extracted in the presence of 50 
mM iodoacetamide. Extracts were cleared by centrifugation at 12,00xg for 5 
minutes. Protein-A sepharose (PAS) (Pharmacia) beads were coated with 
Rabbit anti-mouse Ig antibodies (RAM) (kindly provided by Dr. Nicholas 
Chiorazzi). Extracts were precleared by incubation with RAM-PAS for 2 
hours. RAM-PAS beads were incubated with mouse monoclonal antibodies for 7 
hours, and added to precleared cell extracts. Immunoprecipitation was 
carried out for 5-15 hours, and was followed by washing with TO mM Tris pH 
8, 0.5% NP-40, 0.15 M NaCl, 1 mM EDTA, 1 mg/ml ovalbumin. Elution and gel 
analysis were carried out as described, above. 
Recombinant DNA methods; 
Synthesis of souble stranded, linker ligated cnNA. Ttie methods employ 
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standard technologies (Maniatis) with a few exceptions. First strand 
synthesis was carried out in the presence of actinomycin D. Ttie second 
strand reaction was essentially a nick translation utilizing RNase H, e. 
coli DNA polymerase I, and e. coli DNA ligase. Following filling ends and 
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methylation, linker ligation was carried out using P-labeled Eco Ri 
linkers. Figure "^l shows an auto radiograph of a gel used to monitor linker 
ligation, before and after Eco Rl digestion. Cut linkers were separated 
from linker-ligated cDNA using a 1 ml sepharose C1-4B column. 
Preparation and ligation of phage DNAs Lambda GTIO and GT11 DNAs are 
isolated by phenol extraction from CsCl gradient purified phage (Maniatas). 
Dialysis must be carried out because of a ligation inhibitor in the Cs. 
Both of these phage systems utilize an Eco Rl site for cDNA insertion. Eco 
Rl cleavage is carried out for the purified DNA and monitored by gel 
analysis in 0.5% agarose gels (in TE), an example of which is shown in 
Figure 32. 
The ratio of lambda anns to ds cDNA should be about 5-18ug arms to lOO 
ng ds CDNA (2-3x molar excess). Freshly digested arms are mixed with the 
CDMA, and ligation is carried out as follows: 
8 ul H20 with cDNA and lambda arms 
2 ul 5x ligase buffer 
1 ul T4 DNA ligase 
Incubate at 15 C overnight Success of this ligation reaction may 
32 
be monitored by testing for the presence of P-labeled phage-sized DNA on 
a 0.5% agarose gel. An example is shown in Figure 33 in which recombinant 
cDNA (ligated to phage DNA) is visualized near the origin, as well as 
unligated cDNA of smaller size. 
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Ttie DNA is now packaged using lysates of mutant phage as described 
(Maniatas). 
Bacterial strains 
In the Lambda GtIO cloning system, two bacterial strains are used: 
C500 and HFL (High Frequency of Lysogeny - a mutant of C500). In the HFL 
strain, all lambda phage containing an intact repressor gene will 
lysogenize into the host strain resulting in no lysis (or a minimal 
background of turbid lysis) during infection. In this cloning system, ds 
cDNAs are inserted into a unique Eco Rl in the lambda repressor. Such 
reccmbinant phage, with an interrupted repressor gene can now cause lysis 
in the HFL strain, and can therefore be propagated using this cell line. 
Ttiis is also the method by which one selects recombinant phage. Ttie C^oo 
strain will lyse upon infection by lambda GTIO regardless of whether the 
repressor is intact or not. However, recombinant phage will show clear 
plaques and normal lambda GTIO will show turbid plaques. Using C5oo^ ©ne 
can determine the proportion of recombinant phage for a given cloning 
experiment. 
In the Lambda GTll cloning system, ds cDNA is inserted into the B-
galactosidase gene via a unique Eco Rl site. Ttiere are no strains which 
can select for recombinant phage. Lambda GTll will NOT form plaques on HFL 
or C500. Lambda GTll cx>ntains two mutations v^ich are of importance for 
expression of hybrid galactosidase proteins: a temperature-sensitive 
repressor (CT«5'') and an amber mutation in a gene required for lysis 
(S100). Ttierefore, at elevated temperatures, plaques will form on C50o 
(42° C) , and turbid plaques will form on Le302 at 37° c. Tb determine the 
proportion of recombinant phage in a library for a given cloning experiment 
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one plates the phage on the bacterial strain Yiooo (which will lyse upon 
infection by lambda GTll and does not contain an endogenous galactosidase 
gene) using the indicators IPTG and XGAL. One then scores for reccmbinant 
phage (clear plaques) or intact phage (blue plaques). 2. Plating 
Procedure 
For plating onto an 82nm plate the following procedure is used: 
Add 1-3 ul phage 
200 ul of overnight bacteria 
200 ul of 10 mM MgCl7 
Incubate for 20 minutes at 77 C 
Add 4 ml of soft agarose (Kept at 55 C) 
= 1 gm NZamine 
0.5 gm yeast extract 
0.5 gm NaCl 
0.2 gm MgCl2 
0.7 gm agarose 
100 ml H20 autoclave mix 
Pour onto L broth plates 
Screening and Northern blot analysis are carried out as described 
(Maniatas) . For Northern blots, formaldehyde gels are used. For 
screening, DNA probes are generated by nick translation. For expression 
vector screening, antibodies are mixed with a solution as follows: 1:iOO 
dilution of serum, 20% supernatent frcxn overnight culture of (lysed) gtll 
phage-bacteria, 10 mM Tris pH 7.4, 150 mM NaCl, 3% bovine serum albumin. 
Filters are incubated with this solution for 1 hour, followed by 5 1^ 
minute washes in 0.5% NP-40, 10 mM Tris pH 7.4, isn mM NaCL. A last wash 
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is carried out in the absence of detergent. Following "* hour incubation in 
10 mM Tris pH 7.4, 150 mM NaCl, 7% BSA, containing lo"* cpm per ml i"'2'^ 
protein A (New England Nuclear) the filters are washed with detergent, as 
before. 
Figure 31 
Linker ligation lac3der. Products of the ligation reaction between cDNA and 
Eco Rl linkers are seen in the lane marked "Lig." After digestion with Eco 
Rl, moncxneric linkers are seen near the bottom of the gel (7% acrylamide), 
72 
while linker ligated ( P- labeled) cDNA is seen at the top of the lane 





Fragments generated by digestion of DNA from lambda gtll with Eco Rl. 
Marker DNA's (M) migrate at 15 and 20 kilobases. Two bands of 
approximately 18 and 22 kb are the cleavage products of Eco RT digested 
(H/Ri) phage DMA. A third band migrating at 45-5o kb in the 11/Pi lane 





Diagnostic test for the presence of recombinant DNA molecules. Following 
ligation of cDNA to RVcut phage, an aliquot is resolved on a o.<;% agarose 
gel. On such a gel, unligated cDNA runs as a broad fraction (labeled 
"cDNA") v^ereas phage DNA, being so much larger remains near the origin. 
77 
Since the phage DNA itself had not been P-labeled prior to ligation, the 
presence of counts in this slow migrating fraction indicates successful 
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